BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1332400 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wU:34.38,wD:37.45,14.14,(4.5,-4.2,;4.5,-2.66,;3.16,-1.89,;1.83,-2.66,;.5,-1.89,;-.84,-2.66,;-1.16,-4.17,;-2.69,-4.33,;-3.32,-2.92,;-4.78,-2.45,;-5.1,-.94,;-6.59,-.54,;-7.68,-1.63,;-9.16,-1.23,;-10.25,-2.32,;-9.85,-3.81,;-11.74,-1.92,;-12.83,-3.01,;-14.32,-2.61,;-14.72,-1.12,;-16.2,-.73,;-13.63,-.04,;-14.03,1.45,;-12.94,2.54,;-13.33,4.03,;-11.45,2.14,;-11.05,.65,;-12.14,-.43,;-3.96,.09,;-3.96,1.63,;-2.49,2.11,;-1.59,.86,;-2.49,-.38,;-2.17,-1.89,;5.83,-1.89,;5.83,-.35,;7.16,.42,;8.5,-.35,;8.5,-1.89,;7.16,-2.66,;9.83,.42,;11.17,-.35,;11.17,-1.89,;12.5,.42,;13.83,1.19,;13.83,-.35,;13.83,-1.89,;15.3,-2.37,;16.2,-1.12,;15.3,.12,;12.5,1.96,;13.75,2.86,;13.27,4.33,;11.73,4.33,;11.25,2.86,)| InChI=1S/C41H46N6O6S2/c1-46(26-10-12-27(13-11-26)53-40(51)41(52,35-8-3-20-54-35)36-9-4-21-55-36)18-5-19-47-39-31-7-2-6-28(31)25(22-32(39)44-45-47)23-42-24-34(49)29-14-16-33(48)38-30(29)15-17-37(50)43-38/h3-4,8-9,14-17,20-22,26-27,34,42,48-49,52H,2,5-7,10-13,18-19,23-24H2,1H3,(H,43,50) IBNSRKXSITXGAZ-UHFFFAOYSA-N 624859 US20230322745, Compound 1::US20250230148, Compound of formula (I) Beta-2 adrenergic receptor Homo sapiens 3.47 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624859&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422802 485207226 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332401 O[C@@H](CNCc1cc2nnn(CCCN3CC4(CC(C4)OC(=O)C(O)(c4cccs4)c4cccs4)C3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C40H42N6O6S2/c47-31-11-9-27(28-10-12-35(49)42-36(28)31)32(48)21-41-20-24-17-30-37(29-6-1-5-26(24)29)46(44-43-30)14-4-13-45-22-39(23-45)18-25(19-39)52-38(50)40(51,33-7-2-15-53-33)34-8-3-16-54-34/h2-3,7-12,15-17,25,32,41,47-48,51H,1,4-6,13-14,18-23H2,(H,42,49) JVLPTRADAMESMA-UHFFFAOYSA-N 624877 US20230322745, Compound 2 Beta-2 adrenergic receptor Homo sapiens 0.889 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624877 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624877&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422807 485207244 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332402 O[C@@H](CNCc1cc2nnn(CCCN3CC4(C3)CCC(CC4)OC(=O)C(O)(c3cccs3)c3cccs3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O6S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)23-43-22-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)18-4-17-47-24-41(25-47)15-13-27(14-16-41)54-40(52)42(53,35-7-2-19-55-35)36-8-3-20-56-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) HPLOBWSINMYAFD-UHFFFAOYSA-N 624878 US20230322745, Compound 4 Beta-2 adrenergic receptor Homo sapiens 2.15 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624878 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624878&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422808 485207245 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332403 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(s1)C(C)(C)C |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(2.96,2.9,;2.96,4.44,;1.62,5.21,;.29,4.44,;-1.04,5.21,;-2.38,4.44,;-2.7,2.93,;-4.23,2.77,;-4.86,4.18,;-6.32,4.65,;-6.64,6.16,;-8.13,6.56,;-9.22,5.47,;-10.7,5.87,;-11.79,4.78,;-11.39,3.29,;-13.28,5.18,;-14.37,4.09,;-15.86,4.49,;-16.26,5.97,;-17.74,6.37,;-15.17,7.06,;-15.57,8.55,;-14.48,9.64,;-14.87,11.13,;-12.99,9.24,;-12.59,7.75,;-13.68,6.66,;-5.5,7.19,;-5.5,8.73,;-4.03,9.2,;-3.13,7.96,;-4.03,6.71,;-3.71,5.21,;4.29,5.21,;4.29,6.75,;5.62,7.52,;6.96,6.75,;6.96,5.21,;5.62,4.44,;8.29,7.52,;9.63,6.75,;9.63,5.21,;10.96,7.52,;12.29,8.29,;10.96,9.06,;12.21,9.96,;11.73,11.43,;10.19,11.43,;9.71,9.96,;12.29,6.75,;12.29,5.21,;13.76,4.73,;14.66,5.98,;13.76,7.22,;16.2,5.98,;16.97,7.31,;16.97,4.64,;17.74,5.98,)| InChI=1S/C45H54N6O6S2/c1-44(2,3)37-18-19-39(59-37)45(56,38-10-6-23-58-38)43(55)57-29-13-11-28(12-14-29)50(4)21-7-22-51-42-33-9-5-8-30(33)27(24-34(42)48-49-51)25-46-26-36(53)31-15-17-35(52)41-32(31)16-20-40(54)47-41/h6,10,15-20,23-24,28-29,36,46,52-53,56H,5,7-9,11-14,21-22,25-26H2,1-4H3,(H,47,54) WKRCJMIFYOLWFQ-UHFFFAOYSA-N 624879 US20230322745, Compound 5 Beta-2 adrenergic receptor Homo sapiens 2.63 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624879&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422809 485207246 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332404 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1ccc(s1)C(C)(C)C |r,wU:34.38,wD:14.14,37.45,(2.96,2.9,;2.96,4.44,;1.62,5.21,;.29,4.44,;-1.04,5.21,;-2.38,4.44,;-2.7,2.93,;-4.23,2.77,;-4.86,4.18,;-6.32,4.65,;-6.64,6.16,;-8.13,6.56,;-9.22,5.47,;-10.7,5.87,;-11.79,4.78,;-11.39,3.29,;-13.28,5.18,;-14.37,4.09,;-15.86,4.49,;-16.26,5.97,;-17.74,6.37,;-15.17,7.06,;-15.57,8.55,;-14.48,9.64,;-14.87,11.13,;-12.99,9.24,;-12.59,7.75,;-13.68,6.66,;-5.5,7.19,;-5.5,8.73,;-4.03,9.2,;-3.13,7.96,;-4.03,6.71,;-3.71,5.21,;4.29,5.21,;4.29,6.75,;5.62,7.52,;6.96,6.75,;6.96,5.21,;5.62,4.44,;8.29,7.52,;9.63,6.75,;9.63,5.21,;10.96,7.52,;12.29,8.29,;10.96,9.06,;12.21,9.96,;11.73,11.43,;10.19,11.43,;9.71,9.96,;12.29,6.75,;12.29,5.21,;13.76,4.73,;14.66,5.98,;13.76,7.22,;16.2,5.98,;16.97,7.31,;16.97,4.64,;17.74,5.98,)| InChI=1S/C45H54N6O6S2/c1-44(2,3)37-18-19-39(59-37)45(56,38-10-6-23-58-38)43(55)57-29-13-11-28(12-14-29)50(4)21-7-22-51-42-33-9-5-8-30(33)27(24-34(42)48-49-51)25-46-26-36(53)31-15-17-35(52)41-32(31)16-20-40(54)47-41/h6,10,15-20,23-24,28-29,36,46,52-53,56H,5,7-9,11-14,21-22,25-26H2,1-4H3,(H,47,54) WKRCJMIFYOLWFQ-UHFFFAOYSA-N 624908 US20230322745, Compound 6 Beta-2 adrenergic receptor Homo sapiens 0.624 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624908 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624908&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422812 485207275 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332405 O[C@@H](CNCc1cc2nnn(CCCN3CCC(CC3)OC(=O)[C@](O)(c3cccs3)c3ccc(Br)s3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C39H41BrN6O6S2/c40-34-11-10-33(54-34)39(51,32-6-2-19-53-32)38(50)52-24-13-17-45(18-14-24)15-3-16-46-37-28-5-1-4-25(28)23(20-29(37)43-44-46)21-41-22-31(48)26-7-9-30(47)36-27(26)8-12-35(49)42-36/h2,6-12,19-20,24,31,41,47-48,51H,1,3-5,13-18,21-22H2,(H,42,49) AWTNFLSDGKDYCY-UHFFFAOYSA-N 624910 US20230322745, Compound 8 Beta-2 adrenergic receptor Homo sapiens 1.62 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624910 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624910&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422813 485207277 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332406 O[C@@H](CNCc1cc2nnn(CCCN3CCC(CC3)OC(=O)C(O)(c3cccs3)c3ccc(Br)s3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C39H41BrN6O6S2/c40-34-11-10-33(54-34)39(51,32-6-2-19-53-32)38(50)52-24-13-17-45(18-14-24)15-3-16-46-37-28-5-1-4-25(28)23(20-29(37)43-44-46)21-41-22-31(48)26-7-9-30(47)36-27(26)8-12-35(49)42-36/h2,6-12,19-20,24,31,41,47-48,51H,1,3-5,13-18,21-22H2,(H,42,49) AWTNFLSDGKDYCY-UHFFFAOYSA-N 624912 US20230322745, Compound 9 Beta-2 adrenergic receptor Homo sapiens 6.74 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624912 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624912&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422815 485207279 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332407 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1ccc(Cl)s1)c1ccc(Cl)s1 |r,wU:34.38,wD:14.14,37.45,(3.95,-6.17,;4.35,-4.68,;3.26,-3.59,;1.77,-3.99,;.68,-2.9,;-.81,-3.3,;-1.43,-4.71,;-2.96,-4.55,;-3.28,-3.04,;-4.62,-2.27,;-4.62,-.73,;-5.95,.04,;-7.29,-.73,;-8.62,.04,;-9.95,-.73,;-9.95,-2.27,;-11.29,.04,;-12.62,-.73,;-13.95,.04,;-13.95,1.58,;-15.29,2.35,;-12.62,2.35,;-12.62,3.89,;-11.29,4.66,;-11.29,6.2,;-9.95,3.89,;-9.95,2.35,;-11.29,1.58,;-3.28,.04,;-2.96,1.55,;-1.43,1.71,;-.81,.3,;-1.95,-.73,;-1.95,-2.27,;5.83,-4.28,;6.23,-2.8,;7.72,-2.4,;8.81,-3.49,;8.41,-4.97,;6.92,-5.37,;10.3,-3.09,;10.7,-1.6,;9.61,-.51,;12.18,-1.2,;13.67,-.8,;12.58,.29,;11.68,1.53,;12.58,2.78,;14.05,2.3,;15.13,3.39,;14.05,.76,;13.27,-2.29,;14.81,-2.29,;15.29,-3.75,;14.04,-4.66,;14.04,-6.2,;12.8,-3.75,)| InChI=1S/C41H44Cl2N6O6S2/c1-48(24-6-8-25(9-7-24)55-40(53)41(54,33-13-15-35(42)56-33)34-14-16-36(43)57-34)18-3-19-49-39-29-5-2-4-26(29)23(20-30(39)46-47-49)21-44-22-32(51)27-10-12-31(50)38-28(27)11-17-37(52)45-38/h10-17,20,24-25,32,44,50-51,54H,2-9,18-19,21-22H2,1H3,(H,45,52) FLAAUKBTPUMXAW-UHFFFAOYSA-N 624943 US20230322745, Compound 10 Beta-2 adrenergic receptor Homo sapiens 1.36 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624943 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624943&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422834 485207310 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332408 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3cnn(C)c3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wU:35.39,wD:38.46,14.14,(4.5,-4.2,;4.5,-2.66,;3.16,-1.89,;1.83,-2.66,;.5,-1.89,;-.84,-2.66,;-1.16,-4.17,;-2.69,-4.33,;-3.32,-2.92,;-4.78,-2.45,;-5.1,-.94,;-6.59,-.54,;-7.68,-1.63,;-9.16,-1.23,;-10.25,-2.32,;-9.85,-3.81,;-11.74,-1.92,;-12.83,-3.01,;-14.32,-2.61,;-14.72,-1.12,;-16.2,-.73,;-13.63,-.04,;-14.03,1.45,;-12.94,2.54,;-13.33,4.03,;-11.45,2.14,;-11.05,.65,;-12.14,-.43,;-3.96,.09,;-3.96,1.63,;-2.49,2.11,;-1.59,.86,;-.05,.86,;-2.49,-.38,;-2.17,-1.89,;5.83,-1.89,;5.83,-.35,;7.16,.42,;8.5,-.35,;8.5,-1.89,;7.16,-2.66,;9.83,.42,;11.17,-.35,;11.17,-1.89,;12.5,.42,;13.83,1.19,;13.83,-.35,;13.83,-1.89,;15.3,-2.37,;16.2,-1.12,;15.3,.12,;12.5,1.96,;13.75,2.86,;13.27,4.33,;11.73,4.33,;11.25,2.86,)| InChI=1S/C40H44N8O6S2/c1-46(25-8-10-26(11-9-25)54-39(52)40(53,33-6-3-18-55-33)34-7-4-19-56-34)16-5-17-48-38-30(44-45-48)20-24(29-22-42-47(2)37(29)38)21-41-23-32(50)27-12-14-31(49)36-28(27)13-15-35(51)43-36/h3-4,6-7,12-15,18-20,22,25-26,32,41,49-50,53H,5,8-11,16-17,21,23H2,1-2H3,(H,43,51) GJLQIWOFIGFHLI-UHFFFAOYSA-N 624944 US20230322745, Compound 11 Beta-2 adrenergic receptor Homo sapiens 1.12 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624944&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422835 485207311 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332409 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCCOc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wU:35.39,wD:14.14,38.46,(3.95,-6.18,;4.35,-4.7,;3.26,-3.61,;1.77,-4.01,;.68,-2.92,;-.81,-3.32,;-1.43,-4.72,;-2.96,-4.56,;-3.28,-3.06,;-4.62,-2.29,;-4.62,-.75,;-5.95,.02,;-7.29,-.75,;-8.62,.02,;-9.95,-.75,;-9.95,-2.29,;-11.29,.02,;-12.62,-.75,;-13.95,.02,;-13.95,1.56,;-15.29,2.33,;-12.62,2.33,;-12.62,3.87,;-11.29,4.64,;-11.29,6.18,;-9.95,3.87,;-9.95,2.33,;-11.29,1.56,;-3.28,.02,;-3.28,1.56,;-1.95,2.33,;-.62,1.56,;-.62,.02,;-1.95,-.75,;-1.95,-2.29,;5.83,-4.3,;6.23,-2.81,;7.72,-2.41,;8.81,-3.5,;8.41,-4.99,;6.92,-5.39,;10.3,-3.1,;10.7,-1.62,;9.61,-.53,;12.18,-1.22,;13.67,-.82,;12.58,.27,;11.68,1.52,;12.58,2.76,;14.05,2.29,;14.05,.75,;13.27,-2.31,;14.81,-2.31,;15.29,-3.77,;14.04,-4.68,;12.8,-3.77,)| InChI=1S/C40H44N6O8S2/c1-45(25-7-9-26(10-8-25)54-39(50)40(51,32-5-2-19-55-32)33-6-3-20-56-33)15-4-16-46-36-29(43-44-46)21-24(37-38(36)53-18-17-52-37)22-41-23-31(48)27-11-13-30(47)35-28(27)12-14-34(49)42-35/h2-3,5-6,11-14,19-21,25-26,31,41,47-48,51H,4,7-10,15-18,22-23H2,1H3,(H,42,49) XWGAUAHGYLHPTG-UHFFFAOYSA-N 624945 US20230322745, Compound 12 Beta-2 adrenergic receptor Homo sapiens 2.04 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624945 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624945&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422836 485207312 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332410 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C42H48N6O6S2/c1-25-9-17-37(56-25)42(53,36-8-4-21-55-36)41(52)54-28-12-10-27(11-13-28)47(2)19-5-20-48-40-32-7-3-6-29(32)26(22-33(40)45-46-48)23-43-24-35(50)30-14-16-34(49)39-31(30)15-18-38(51)44-39/h4,8-9,14-18,21-22,27-28,35,43,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,44,51) BDWSAAGKPWOYAA-UHFFFAOYSA-N 624946 US20230322745, Compound 13 Beta-2 adrenergic receptor Homo sapiens 1.73 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624946 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624946&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422837 485207313 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332411 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1ccc(C)s1 |r,wU:34.38,wD:14.14,37.45,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C42H48N6O6S2/c1-25-9-17-37(56-25)42(53,36-8-4-21-55-36)41(52)54-28-12-10-27(11-13-28)47(2)19-5-20-48-40-32-7-3-6-29(32)26(22-33(40)45-46-48)23-43-24-35(50)30-14-16-34(49)39-31(30)15-18-38(51)44-39/h4,8-9,14-18,21-22,27-28,35,43,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,44,51) BDWSAAGKPWOYAA-UHFFFAOYSA-N 624947 US20230322745, Compound 14 Beta-2 adrenergic receptor Homo sapiens 1.40 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624947&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422838 485207314 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332412 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Br)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C41H45BrN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) RAXKPRMYCBJHGZ-UHFFFAOYSA-N 624948 US20230322745, Compound 16::US20230322745, Compound 15 Beta-2 adrenergic receptor Homo sapiens 1.89 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624948&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422839 485207315 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332413 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Br)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C41H45BrN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) RAXKPRMYCBJHGZ-UHFFFAOYSA-N 624948 US20230322745, Compound 16::US20230322745, Compound 15 Beta-2 adrenergic receptor Homo sapiens 2.16 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624948&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422839 485207315 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332414 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(CC(C4)OC(=O)C(O)(c4ccc(Cl)s4)c4ccc(Cl)s4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H44Cl2N6O6S2/c43-35-10-8-33(57-35)42(55,34-9-11-36(44)58-34)40(54)56-25-20-41(21-25)13-17-49(18-14-41)15-2-16-50-39-29-4-1-3-26(29)24(19-30(39)47-48-50)22-45-23-32(52)27-5-7-31(51)38-28(27)6-12-37(53)46-38/h5-12,19,25,32,45,51-52,55H,1-4,13-18,20-23H2,(H,46,53) SRFLTTOQPVNVGB-UHFFFAOYSA-N 624950 US20230322745, Compound 19 Beta-2 adrenergic receptor Homo sapiens 5.14 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624950 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624950&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422840 485207316 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332415 O[C@@H](CNCc1cc2nnn(CCCN3CC4(CC(C4)OC(=O)C(O)(c4cccs4)c4cc5ccccc5s4)C3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C44H44N6O6S2/c51-34-13-11-30(31-12-14-39(53)46-40(31)34)35(52)23-45-22-27-18-33-41(32-8-3-7-29(27)32)50(48-47-33)16-5-15-49-24-43(25-49)20-28(21-43)56-42(54)44(55,37-10-4-17-57-37)38-19-26-6-1-2-9-36(26)58-38/h1-2,4,6,9-14,17-19,28,35,45,51-52,55H,3,5,7-8,15-16,20-25H2,(H,46,53) XLLKIFCSOJPTBQ-UHFFFAOYSA-N 624951 US20230322745, Compound 21 Beta-2 adrenergic receptor Homo sapiens 2.11 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624951 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624951&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422841 485207317 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332416 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@H](CC(=O)[C@](O)(c2cccs2)c2ccc(s2)-c2ccccc2)CC1 |r,wU:34.38,41.46,wD:14.14,37.42,41.47,(3.5,-10.26,;3.5,-8.72,;2.17,-7.95,;.83,-8.72,;-.5,-7.95,;-1.84,-8.72,;-2.08,-10.25,;-3.6,-10.49,;-4.3,-9.11,;-5.78,-8.72,;-6.18,-7.23,;-7.67,-6.83,;-8.76,-7.92,;-10.25,-7.52,;-11.34,-8.61,;-10.94,-10.1,;-12.82,-8.21,;-13.91,-9.3,;-15.4,-8.9,;-15.8,-7.41,;-17.29,-7.01,;-14.71,-6.32,;-15.11,-4.84,;-14.02,-3.75,;-14.42,-2.26,;-12.53,-4.15,;-12.13,-5.63,;-13.22,-6.72,;-5.09,-6.14,;-5.17,-4.6,;-3.74,-4.05,;-2.77,-5.25,;-3.61,-6.54,;-3.21,-8.02,;4.83,-7.95,;4.83,-6.41,;6.17,-5.64,;7.5,-6.41,;8.83,-5.64,;10.17,-6.41,;10.17,-7.95,;11.5,-5.64,;12.83,-4.87,;11.5,-4.1,;10.25,-3.2,;10.73,-1.73,;12.27,-1.73,;12.75,-3.2,;12.83,-6.41,;14.24,-5.79,;15.27,-6.93,;14.5,-8.27,;13,-7.95,;15.13,-9.67,;14.22,-10.92,;14.85,-12.33,;16.38,-12.49,;17.29,-11.24,;16.66,-9.83,;7.5,-7.95,;6.17,-8.72,)| InChI=1S/C48H52N6O5S2/c1-53(33-15-13-30(14-16-33)26-42(57)48(59,43-12-6-25-60-43)44-21-20-41(61-44)31-8-3-2-4-9-31)23-7-24-54-47-37-11-5-10-34(37)32(27-38(47)51-52-54)28-49-29-40(56)35-17-19-39(55)46-36(35)18-22-45(58)50-46/h2-4,6,8-9,12,17-22,25,27,30,33,40,49,55-56,59H,5,7,10-11,13-16,23-24,26,28-29H2,1H3,(H,50,58) TZIMVIINTYPOMM-UHFFFAOYSA-N 624970 US20230322745, Compound 22 Beta-2 adrenergic receptor Homo sapiens 20.8 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624970 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624970&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422860 485207336 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332417 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@H](CC(=O)[C@@](O)(c2cccs2)c2ccc(s2)-c2ccccc2)CC1 |r,wU:34.38,41.47,wD:14.14,37.42,41.46,(3.5,-10.26,;3.5,-8.72,;2.17,-7.95,;.83,-8.72,;-.5,-7.95,;-1.84,-8.72,;-2.08,-10.25,;-3.6,-10.49,;-4.3,-9.11,;-5.78,-8.72,;-6.18,-7.23,;-7.67,-6.83,;-8.76,-7.92,;-10.25,-7.52,;-11.34,-8.61,;-10.94,-10.1,;-12.82,-8.21,;-13.91,-9.3,;-15.4,-8.9,;-15.8,-7.41,;-17.29,-7.01,;-14.71,-6.32,;-15.11,-4.84,;-14.02,-3.75,;-14.42,-2.26,;-12.53,-4.15,;-12.13,-5.63,;-13.22,-6.72,;-5.09,-6.14,;-5.17,-4.6,;-3.74,-4.05,;-2.77,-5.25,;-3.61,-6.54,;-3.21,-8.02,;4.83,-7.95,;4.83,-6.41,;6.17,-5.64,;7.5,-6.41,;8.83,-5.64,;10.17,-6.41,;10.17,-7.95,;11.5,-5.64,;12.83,-4.87,;11.5,-4.1,;10.25,-3.2,;10.73,-1.73,;12.27,-1.73,;12.75,-3.2,;12.83,-6.41,;14.24,-5.79,;15.27,-6.93,;14.5,-8.27,;13,-7.95,;15.13,-9.67,;14.22,-10.92,;14.85,-12.33,;16.38,-12.49,;17.29,-11.24,;16.66,-9.83,;7.5,-7.95,;6.17,-8.72,)| InChI=1S/C48H52N6O5S2/c1-53(33-15-13-30(14-16-33)26-42(57)48(59,43-12-6-25-60-43)44-21-20-41(61-44)31-8-3-2-4-9-31)23-7-24-54-47-37-11-5-10-34(37)32(27-38(47)51-52-54)28-49-29-40(56)35-17-19-39(55)46-36(35)18-22-45(58)50-46/h2-4,6,8-9,12,17-22,25,27,30,33,40,49,55-56,59H,5,7,10-11,13-16,23-24,26,28-29H2,1H3,(H,50,58) TZIMVIINTYPOMM-UHFFFAOYSA-N 624972 US20230322745, Compound 23 Beta-2 adrenergic receptor Homo sapiens 16.8 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624972&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422862 485207338 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332418 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(C[C@H](CO4)OC(=O)C(O)(c4cccs4)c4cccs4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O7S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)24-43-23-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)16-4-15-47-17-13-41(14-18-47)22-27(25-54-41)55-40(52)42(53,35-7-2-19-56-35)36-8-3-20-57-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) OYKGMOVRDZQXJB-UHFFFAOYSA-N 624953 US20230322745, Compound 24 Beta-2 adrenergic receptor Homo sapiens 158 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624953 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624953&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422843 485207319 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332419 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(C[C@@H](CO4)OC(=O)C(O)(c4cccs4)c4cccs4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O7S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)24-43-23-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)16-4-15-47-17-13-41(14-18-47)22-27(25-54-41)55-40(52)42(53,35-7-2-19-56-35)36-8-3-20-57-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) OYKGMOVRDZQXJB-UHFFFAOYSA-N 624955 US20230322745, Compound 25 Beta-2 adrenergic receptor Homo sapiens 0.388 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624955 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624955&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422845 485207321 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332420 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Cl)s1 |r,wU:37.45,43.49,wD:14.14,43.50,(3.77,3.25,;4.17,4.74,;3.08,5.83,;1.59,5.43,;.5,6.52,;-.98,6.12,;-1.61,4.72,;-3.14,4.88,;-3.46,6.38,;-4.8,7.15,;-4.8,8.69,;-6.13,9.46,;-7.46,8.69,;-8.8,9.46,;-10.13,8.69,;-10.13,7.15,;-11.46,9.46,;-12.8,8.69,;-14.13,9.46,;-14.13,11,;-15.46,11.77,;-12.8,11.77,;-12.8,13.31,;-11.46,14.08,;-11.46,15.62,;-10.13,13.31,;-10.13,11.77,;-11.46,11,;-3.46,9.46,;-3.14,10.97,;-1.61,11.13,;-.98,9.72,;-2.13,8.69,;-2.13,7.15,;5.66,5.14,;6.75,4.05,;8.23,4.45,;8.63,5.94,;7.54,7.03,;6.06,6.63,;10.12,6.34,;10.52,7.82,;9.43,8.91,;12.01,8.22,;13.49,8.62,;12.4,9.71,;11.44,10.91,;12.27,12.2,;13.76,11.8,;13.84,10.26,;13.09,7.13,;14.56,7.61,;15.46,6.36,;14.56,5.12,;15.04,3.65,;13.09,5.59,)| InChI=1S/C41H45ClN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) CZFARYRCUMIUSD-UHFFFAOYSA-N 624956 US20230322745, Compound 28 Beta-2 adrenergic receptor Homo sapiens 1.41 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624956&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422846 485207322 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332421 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(Cl)s1 |r,wU:37.45,43.50,wD:14.14,43.49,(3.77,3.25,;4.17,4.74,;3.08,5.83,;1.59,5.43,;.5,6.52,;-.98,6.12,;-1.61,4.72,;-3.14,4.88,;-3.46,6.38,;-4.8,7.15,;-4.8,8.69,;-6.13,9.46,;-7.46,8.69,;-8.8,9.46,;-10.13,8.69,;-10.13,7.15,;-11.46,9.46,;-12.8,8.69,;-14.13,9.46,;-14.13,11,;-15.46,11.77,;-12.8,11.77,;-12.8,13.31,;-11.46,14.08,;-11.46,15.62,;-10.13,13.31,;-10.13,11.77,;-11.46,11,;-3.46,9.46,;-3.14,10.97,;-1.61,11.13,;-.98,9.72,;-2.13,8.69,;-2.13,7.15,;5.66,5.14,;6.75,4.05,;8.23,4.45,;8.63,5.94,;7.54,7.03,;6.06,6.63,;10.12,6.34,;10.52,7.82,;9.43,8.91,;12.01,8.22,;13.49,8.62,;12.4,9.71,;11.44,10.91,;12.27,12.2,;13.76,11.8,;13.84,10.26,;13.09,7.13,;14.56,7.61,;15.46,6.36,;14.56,5.12,;15.04,3.65,;13.09,5.59,)| InChI=1S/C41H45ClN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) CZFARYRCUMIUSD-UHFFFAOYSA-N 624957 US20230322745, Compound 29 Beta-2 adrenergic receptor Homo sapiens 2.73 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624957 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624957&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422847 485207323 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332422 C[N+]1(CCCn2nnc3cc(CNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)c4CCCc4c23)CCC(CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,(3.8,.2,;5.14,.97,;3.67,1.44,;2.53,.41,;1.06,.89,;-.08,-.14,;.08,-1.67,;-1.33,-2.3,;-2.36,-1.16,;-3.9,-1.16,;-4.67,.18,;-6.21,.18,;-6.98,-1.16,;-8.52,-1.16,;-9.29,-2.49,;-8.52,-3.82,;-10.83,-2.49,;-11.6,-3.82,;-13.14,-3.82,;-13.91,-2.49,;-15.45,-2.49,;-13.14,-1.16,;-13.91,.18,;-13.14,1.51,;-13.91,2.85,;-11.6,1.51,;-10.83,.18,;-11.6,-1.16,;-3.9,1.51,;-4.37,2.98,;-3.13,3.88,;-1.88,2.98,;-2.36,1.51,;-1.59,.18,;5.46,-.54,;6.92,-1.02,;8.07,.02,;7.75,1.52,;6.28,2,;9.53,-.46,;10.67,.57,;10.35,2.08,;12.14,.09,;13.63,-.3,;13.23,1.18,;12.99,2.7,;14.36,3.4,;15.45,2.31,;14.75,.94,;12.54,-1.39,;13.98,-1.95,;13.89,-3.48,;12.41,-3.88,;11.57,-2.59,)| InChI=1S/C40H44N6O6S2/c1-46(18-14-26(15-19-46)52-39(50)40(51,34-8-3-20-53-34)35-9-4-21-54-35)17-5-16-45-38-30-7-2-6-27(30)25(22-31(38)43-44-45)23-41-24-33(48)28-10-12-32(47)37-29(28)11-13-36(49)42-37/h3-4,8-13,20-22,26,33,41,48,51H,2,5-7,14-19,23-24H2,1H3,(H-,42,43,44,47,49)/p+1 IEFAHOCPMRQNBE-UHFFFAOYSA-O 624958 US20230322745, Compound 30 Beta-2 adrenergic receptor Homo sapiens 1.71 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624958 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624958&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422848 485207324 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332423 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@H](CC(=O)C(O)(c2ccc(C)s2)c2ccc(C)s2)CC1 |r,wU:34.38,wD:14.14,37.42,(4.51,-4.78,;4.51,-3.24,;3.17,-2.47,;1.84,-3.24,;.5,-2.47,;-.83,-3.24,;-1.07,-4.76,;-2.59,-5,;-3.29,-3.63,;-4.78,-3.23,;-5.18,-1.74,;-6.66,-1.34,;-7.75,-2.43,;-9.24,-2.03,;-10.33,-3.12,;-9.93,-4.61,;-11.82,-2.72,;-12.91,-3.81,;-14.39,-3.41,;-14.79,-1.93,;-16.28,-1.53,;-13.7,-.84,;-14.1,.65,;-13.01,1.74,;-13.41,3.23,;-11.52,1.34,;-11.13,-.15,;-12.22,-1.24,;-4.09,-.65,;-4.17,.89,;-2.73,1.44,;-1.76,.24,;-2.6,-1.05,;-2.2,-2.54,;5.84,-2.47,;5.84,-.93,;7.17,-.16,;8.51,-.93,;9.84,-.16,;11.17,-.93,;11.17,-2.47,;12.51,-.16,;13.84,.61,;13.84,-.93,;15.25,-.3,;16.28,-1.44,;15.51,-2.78,;16.14,-4.19,;14,-2.46,;12.51,1.38,;11.26,2.29,;11.74,3.75,;13.28,3.75,;14.18,5,;13.75,2.29,;8.51,-2.47,;7.17,-3.24,)| InChI=1S/C44H52N6O5S2/c1-26-8-17-39(56-26)44(55,40-18-9-27(2)57-40)38(53)22-28-10-12-30(13-11-28)49(3)20-5-21-50-43-34-7-4-6-31(34)29(23-35(43)47-48-50)24-45-25-37(52)32-14-16-36(51)42-33(32)15-19-41(54)46-42/h8-9,14-19,23,28,30,37,45,51-52,55H,4-7,10-13,20-22,24-25H2,1-3H3,(H,46,54) JSDLJSSEKWSNAT-UHFFFAOYSA-N 624959 US20230322745, Compound 32 Beta-2 adrenergic receptor Homo sapiens 1.57 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624959&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422849 485207325 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332424 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C39H42N6O8S2/c1-44(24-7-9-25(10-8-24)53-38(49)39(50,31-5-2-17-54-31)32-6-3-18-55-32)15-4-16-45-35-28(42-43-45)19-23(36-37(35)52-22-51-36)20-40-21-30(47)26-11-13-29(46)34-27(26)12-14-33(48)41-34/h2-3,5-6,11-14,17-19,24-25,30,40,46-47,50H,4,7-10,15-16,20-22H2,1H3,(H,41,48) ZYYNDNILFMUVTL-UHFFFAOYSA-N 624960 US20230322745, Compound 33 Beta-2 adrenergic receptor Homo sapiens 0.742 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624960&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422850 485207326 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332425 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,1.47,;4.17,2.96,;3.08,4.04,;1.59,3.65,;.5,4.73,;-.98,4.34,;-1.61,2.93,;-3.14,3.09,;-3.46,4.6,;-4.8,5.37,;-4.8,6.91,;-6.13,7.68,;-7.46,6.91,;-8.8,7.68,;-10.13,6.91,;-10.13,5.37,;-11.46,7.68,;-12.8,6.91,;-14.13,7.68,;-14.13,9.22,;-15.46,9.99,;-12.8,9.99,;-12.8,11.53,;-11.46,12.3,;-11.46,13.84,;-10.13,11.53,;-10.13,9.99,;-11.46,9.22,;-3.46,7.68,;-3.14,9.18,;-1.61,9.34,;-.98,7.94,;-2.13,6.91,;-2.13,5.37,;5.66,3.35,;6.06,4.84,;7.54,5.24,;8.63,4.15,;8.23,2.66,;6.75,2.26,;10.12,4.55,;10.52,6.04,;9.43,7.13,;12.01,6.44,;13.49,6.83,;12.4,7.92,;11.44,9.12,;12.27,10.41,;13.76,10.01,;13.84,8.47,;13.09,5.35,;14.56,5.82,;15.46,4.58,;14.56,3.33,;15.04,1.87,;13.09,3.81,)| InChI=1S/C40H44N6O8S2/c1-23-6-14-33(56-23)40(51,32-5-3-18-55-32)39(50)54-26-9-7-25(8-10-26)45(2)16-4-17-46-36-29(43-44-46)19-24(37-38(36)53-22-52-37)20-41-21-31(48)27-11-13-30(47)35-28(27)12-15-34(49)42-35/h3,5-6,11-15,18-19,25-26,31,41,47-48,51H,4,7-10,16-17,20-22H2,1-2H3,(H,42,49) FYYWKHFZJYSOCA-UHFFFAOYSA-N 624961 US20230322745, Compound 34 Beta-2 adrenergic receptor Homo sapiens 0.405 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624961 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624961&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422851 485207327 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332426 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,1.47,;4.17,2.96,;3.08,4.04,;1.59,3.65,;.5,4.73,;-.98,4.34,;-1.61,2.93,;-3.14,3.09,;-3.46,4.6,;-4.8,5.37,;-4.8,6.91,;-6.13,7.68,;-7.46,6.91,;-8.8,7.68,;-10.13,6.91,;-10.13,5.37,;-11.46,7.68,;-12.8,6.91,;-14.13,7.68,;-14.13,9.22,;-15.46,9.99,;-12.8,9.99,;-12.8,11.53,;-11.46,12.3,;-11.46,13.84,;-10.13,11.53,;-10.13,9.99,;-11.46,9.22,;-3.46,7.68,;-3.14,9.18,;-1.61,9.34,;-.98,7.94,;-2.13,6.91,;-2.13,5.37,;5.66,3.35,;6.06,4.84,;7.54,5.24,;8.63,4.15,;8.23,2.66,;6.75,2.26,;10.12,4.55,;10.52,6.04,;9.43,7.13,;12.01,6.44,;13.49,6.83,;12.4,7.92,;11.44,9.12,;12.27,10.41,;13.76,10.01,;13.84,8.47,;13.09,5.35,;14.56,5.82,;15.46,4.58,;14.56,3.33,;15.04,1.87,;13.09,3.81,)| InChI=1S/C40H44N6O8S2/c1-23-6-14-33(56-23)40(51,32-5-3-18-55-32)39(50)54-26-9-7-25(8-10-26)45(2)16-4-17-46-36-29(43-44-46)19-24(37-38(36)53-22-52-37)20-41-21-31(48)27-11-13-30(47)35-28(27)12-15-34(49)42-35/h3,5-6,11-15,18-19,25-26,31,41,47-48,51H,4,7-10,16-17,20-22H2,1-2H3,(H,42,49) FYYWKHFZJYSOCA-UHFFFAOYSA-N 624962 US20230322745, Compound 35 Beta-2 adrenergic receptor Homo sapiens 0.671 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624962&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422852 485207328 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332427 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,.8,;4.17,2.29,;3.08,3.38,;1.59,2.98,;.5,4.07,;-.98,3.67,;-1.61,2.26,;-3.14,2.42,;-3.46,3.93,;-4.8,4.7,;-4.8,6.24,;-6.13,7.01,;-7.46,6.24,;-8.8,7.01,;-10.13,6.24,;-10.13,4.7,;-11.46,7.01,;-12.8,6.24,;-14.13,7.01,;-14.13,8.55,;-15.46,9.32,;-12.8,9.32,;-12.8,10.86,;-11.46,11.63,;-11.46,13.17,;-10.13,10.86,;-10.13,9.32,;-11.46,8.55,;-3.46,7.01,;-3.14,8.51,;-1.61,8.68,;-.98,7.27,;-2.13,6.24,;-2.13,4.7,;5.66,2.69,;6.06,4.17,;7.54,4.57,;8.63,3.48,;8.23,2,;6.75,1.6,;10.12,3.88,;10.52,5.37,;9.43,6.46,;12.01,5.77,;13.49,6.17,;12.4,7.26,;11.44,8.45,;12.27,9.74,;13.76,9.35,;13.84,7.81,;13.09,4.68,;14.56,5.15,;15.46,3.91,;14.56,2.66,;15.04,1.2,;13.09,3.14,)| InChI=1S/C41H46N6O7S2/c1-24-6-14-36(56-24)41(52,35-5-3-18-55-35)40(51)54-27-9-7-26(8-10-27)46(2)16-4-17-47-39-31-23-53-22-30(31)25(19-32(39)44-45-47)20-42-21-34(49)28-11-13-33(48)38-29(28)12-15-37(50)43-38/h3,5-6,11-15,18-19,26-27,34,42,48-49,52H,4,7-10,16-17,20-23H2,1-2H3,(H,43,50) ITYRYCDVBXJIPH-UHFFFAOYSA-N 624963 US20230322745, Compound 36 Beta-2 adrenergic receptor Homo sapiens 2.45 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624963 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624963&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422853 485207329 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332428 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,.8,;4.17,2.29,;3.08,3.38,;1.59,2.98,;.5,4.07,;-.98,3.67,;-1.61,2.26,;-3.14,2.42,;-3.46,3.93,;-4.8,4.7,;-4.8,6.24,;-6.13,7.01,;-7.46,6.24,;-8.8,7.01,;-10.13,6.24,;-10.13,4.7,;-11.46,7.01,;-12.8,6.24,;-14.13,7.01,;-14.13,8.55,;-15.46,9.32,;-12.8,9.32,;-12.8,10.86,;-11.46,11.63,;-11.46,13.17,;-10.13,10.86,;-10.13,9.32,;-11.46,8.55,;-3.46,7.01,;-3.14,8.51,;-1.61,8.68,;-.98,7.27,;-2.13,6.24,;-2.13,4.7,;5.66,2.69,;6.06,4.17,;7.54,4.57,;8.63,3.48,;8.23,2,;6.75,1.6,;10.12,3.88,;10.52,5.37,;9.43,6.46,;12.01,5.77,;13.49,6.17,;12.4,7.26,;11.44,8.45,;12.27,9.74,;13.76,9.35,;13.84,7.81,;13.09,4.68,;14.56,5.15,;15.46,3.91,;14.56,2.66,;15.04,1.2,;13.09,3.14,)| InChI=1S/C41H46N6O7S2/c1-24-6-14-36(56-24)41(52,35-5-3-18-55-35)40(51)54-27-9-7-26(8-10-27)46(2)16-4-17-47-39-31-23-53-22-30(31)25(19-32(39)44-45-47)20-42-21-34(49)28-11-13-33(48)38-29(28)12-15-37(50)43-38/h3,5-6,11-15,18-19,26-27,34,42,48-49,52H,4,7-10,16-17,20-23H2,1-2H3,(H,43,50) ITYRYCDVBXJIPH-UHFFFAOYSA-N 624964 US20230322745, Compound 37 Beta-2 adrenergic receptor Homo sapiens 1.93 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624964&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422854 485207330 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332429 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,1.68,;4.17,3.17,;3.08,4.26,;1.59,3.86,;.5,4.95,;-.98,4.55,;-1.61,3.15,;-3.14,3.31,;-3.46,4.81,;-4.8,5.58,;-4.8,7.12,;-6.13,7.89,;-7.46,7.12,;-8.8,7.89,;-10.13,7.12,;-10.13,5.58,;-11.46,7.89,;-12.8,7.12,;-14.13,7.89,;-14.13,9.43,;-15.46,10.2,;-12.8,10.2,;-12.8,11.74,;-11.46,12.51,;-11.46,14.05,;-10.13,11.74,;-10.13,10.2,;-11.46,9.43,;-3.46,7.89,;-3.14,9.4,;-1.61,9.56,;-.98,8.15,;-2.13,7.12,;-2.13,5.58,;5.66,3.57,;6.06,5.06,;7.54,5.46,;8.63,4.37,;8.23,2.88,;6.75,2.48,;10.12,4.77,;10.52,6.25,;9.43,7.34,;12.01,6.65,;13.49,7.05,;12.4,8.14,;11.44,9.34,;12.27,10.63,;13.76,10.23,;13.84,8.69,;13.09,5.56,;14.56,6.04,;15.46,4.79,;14.56,3.55,;15.04,2.08,;13.09,4.02,)| InChI=1S/C43H49N5O6S2/c1-26-9-17-38(56-26)43(53,37-8-4-21-55-37)42(52)54-29-12-10-28(11-13-29)47(2)19-5-20-48-25-45-34-22-27(30-6-3-7-33(30)41(34)48)23-44-24-36(50)31-14-16-35(49)40-32(31)15-18-39(51)46-40/h4,8-9,14-18,21-22,25,28-29,36,44,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,46,51) UBDKDGUJMUUUTQ-UHFFFAOYSA-N 624965 US20230322745, Compound 38 Beta-2 adrenergic receptor Homo sapiens 13.5 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624965&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422855 485207331 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332430 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,1.68,;4.17,3.17,;3.08,4.26,;1.59,3.86,;.5,4.95,;-.98,4.55,;-1.61,3.15,;-3.14,3.31,;-3.46,4.81,;-4.8,5.58,;-4.8,7.12,;-6.13,7.89,;-7.46,7.12,;-8.8,7.89,;-10.13,7.12,;-10.13,5.58,;-11.46,7.89,;-12.8,7.12,;-14.13,7.89,;-14.13,9.43,;-15.46,10.2,;-12.8,10.2,;-12.8,11.74,;-11.46,12.51,;-11.46,14.05,;-10.13,11.74,;-10.13,10.2,;-11.46,9.43,;-3.46,7.89,;-3.14,9.4,;-1.61,9.56,;-.98,8.15,;-2.13,7.12,;-2.13,5.58,;5.66,3.57,;6.06,5.06,;7.54,5.46,;8.63,4.37,;8.23,2.88,;6.75,2.48,;10.12,4.77,;10.52,6.25,;9.43,7.34,;12.01,6.65,;13.49,7.05,;12.4,8.14,;11.44,9.34,;12.27,10.63,;13.76,10.23,;13.84,8.69,;13.09,5.56,;14.56,6.04,;15.46,4.79,;14.56,3.55,;15.04,2.08,;13.09,4.02,)| InChI=1S/C43H49N5O6S2/c1-26-9-17-38(56-26)43(53,37-8-4-21-55-37)42(52)54-29-12-10-28(11-13-29)47(2)19-5-20-48-25-45-34-22-27(30-6-3-7-33(30)41(34)48)23-44-24-36(50)31-14-16-35(49)40-32(31)15-18-39(51)46-40/h4,8-9,14-18,21-22,25,28-29,36,44,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,46,51) UBDKDGUJMUUUTQ-UHFFFAOYSA-N 624966 US20230322745, Compound 39 Beta-2 adrenergic receptor Homo sapiens 21.9 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624966&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422856 485207332 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332431 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C40H44N6O7S2/c1-45(25-7-9-26(10-8-25)53-39(50)40(51,34-5-2-17-54-34)35-6-3-18-55-35)15-4-16-46-38-30-23-52-22-29(30)24(19-31(38)43-44-46)20-41-21-33(48)27-11-13-32(47)37-28(27)12-14-36(49)42-37/h2-3,5-6,11-14,17-19,25-26,33,41,47-48,51H,4,7-10,15-16,20-23H2,1H3,(H,42,49) NTARVXTWEZJQNE-UHFFFAOYSA-N 624967 US20230322745, Compound 40 Beta-2 adrenergic receptor Homo sapiens 2.80 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624967 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624967&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422857 485207333 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332432 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C42H47N5O6S2/c1-46(27-10-12-28(13-11-27)53-41(51)42(52,36-8-3-20-54-36)37-9-4-21-55-37)18-5-19-47-25-44-33-22-26(29-6-2-7-32(29)40(33)47)23-43-24-35(49)30-14-16-34(48)39-31(30)15-17-38(50)45-39/h3-4,8-9,14-17,20-22,25,27-28,35,43,48-49,52H,2,5-7,10-13,18-19,23-24H2,1H3,(H,45,50) UFQHICFQEIEWLF-UHFFFAOYSA-N 624969 US20230322745, Compound 41 Beta-2 adrenergic receptor Homo sapiens 13.8 US Patent 10.7270/Q2T157SH aid1919841 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5059&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624969&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422859 485207335 1 MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL 2R4R,6E67 Beta-2 adrenergic receptor ADRB2_HUMAN P07550 B0LPE4 B2R7X2 O14823 O14824 O14825 O14826 Q4JG18 Q53GA6 Q6GMT4 Q6P4D8 Q8NEQ9 Q96EC3 Q9UCZ0 Q9UCZ1 Q9UCZ2 Q9UCZ3 Q9UH95 Q9UHA1 Q9UMZ5 1332433 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wU:34.38,wD:37.45,14.14,(4.5,-4.2,;4.5,-2.66,;3.16,-1.89,;1.83,-2.66,;.5,-1.89,;-.84,-2.66,;-1.16,-4.17,;-2.69,-4.33,;-3.32,-2.92,;-4.78,-2.45,;-5.1,-.94,;-6.59,-.54,;-7.68,-1.63,;-9.16,-1.23,;-10.25,-2.32,;-9.85,-3.81,;-11.74,-1.92,;-12.83,-3.01,;-14.32,-2.61,;-14.72,-1.12,;-16.2,-.73,;-13.63,-.04,;-14.03,1.45,;-12.94,2.54,;-13.33,4.03,;-11.45,2.14,;-11.05,.65,;-12.14,-.43,;-3.96,.09,;-3.96,1.63,;-2.49,2.11,;-1.59,.86,;-2.49,-.38,;-2.17,-1.89,;5.83,-1.89,;5.83,-.35,;7.16,.42,;8.5,-.35,;8.5,-1.89,;7.16,-2.66,;9.83,.42,;11.17,-.35,;11.17,-1.89,;12.5,.42,;13.83,1.19,;13.83,-.35,;13.83,-1.89,;15.3,-2.37,;16.2,-1.12,;15.3,.12,;12.5,1.96,;13.75,2.86,;13.27,4.33,;11.73,4.33,;11.25,2.86,)| InChI=1S/C41H46N6O6S2/c1-46(26-10-12-27(13-11-26)53-40(51)41(52,35-8-3-20-54-35)36-9-4-21-55-36)18-5-19-47-39-31-7-2-6-28(31)25(22-32(39)44-45-47)23-42-24-34(49)29-14-16-33(48)38-30(29)15-17-37(50)43-38/h3-4,8-9,14-17,20-22,26-27,34,42,48-49,52H,2,5-7,10-13,18-19,23-24H2,1H3,(H,43,50) IBNSRKXSITXGAZ-UHFFFAOYSA-N 624859 US20230322745, Compound 1::US20250230148, Compound of formula (I) Muscarinic acetylcholine receptor M3 Homo sapiens 0.384 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624859&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422802 485207226 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332434 O[C@@H](CNCc1cc2nnn(CCCN3CC4(CC(C4)OC(=O)C(O)(c4cccs4)c4cccs4)C3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C40H42N6O6S2/c47-31-11-9-27(28-10-12-35(49)42-36(28)31)32(48)21-41-20-24-17-30-37(29-6-1-5-26(24)29)46(44-43-30)14-4-13-45-22-39(23-45)18-25(19-39)52-38(50)40(51,33-7-2-15-53-33)34-8-3-16-54-34/h2-3,7-12,15-17,25,32,41,47-48,51H,1,4-6,13-14,18-23H2,(H,42,49) JVLPTRADAMESMA-UHFFFAOYSA-N 624877 US20230322745, Compound 2 Muscarinic acetylcholine receptor M3 Homo sapiens 0.347 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624877 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624877&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422807 485207244 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332435 O[C@@H](CNCc1cc2nnn(CCCN3CCC(CC3)OC(=O)C(O)(c3cccs3)c3cccs3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C39H42N6O6S2/c46-31-11-9-27(28-10-12-35(48)41-36(28)31)32(47)23-40-22-24-21-30-37(29-6-1-5-26(24)29)45(43-42-30)16-4-15-44-17-13-25(14-18-44)51-38(49)39(50,33-7-2-19-52-33)34-8-3-20-53-34/h2-3,7-12,19-21,25,32,40,46-47,50H,1,4-6,13-18,22-23H2,(H,41,48) UFUSYSJQWPMJIW-UHFFFAOYSA-N 624973 US20230322745, Compound 3 Muscarinic acetylcholine receptor M3 Homo sapiens 1.11 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624973 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624973&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422863 485207339 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332436 O[C@@H](CNCc1cc2nnn(CCCN3CC4(C3)CCC(CC4)OC(=O)C(O)(c3cccs3)c3cccs3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O6S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)23-43-22-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)18-4-17-47-24-41(25-47)15-13-27(14-16-41)54-40(52)42(53,35-7-2-19-55-35)36-8-3-20-56-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) HPLOBWSINMYAFD-UHFFFAOYSA-N 624878 US20230322745, Compound 4 Muscarinic acetylcholine receptor M3 Homo sapiens 0.343 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624878 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624878&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422808 485207245 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332437 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(s1)C(C)(C)C |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(2.96,2.9,;2.96,4.44,;1.62,5.21,;.29,4.44,;-1.04,5.21,;-2.38,4.44,;-2.7,2.93,;-4.23,2.77,;-4.86,4.18,;-6.32,4.65,;-6.64,6.16,;-8.13,6.56,;-9.22,5.47,;-10.7,5.87,;-11.79,4.78,;-11.39,3.29,;-13.28,5.18,;-14.37,4.09,;-15.86,4.49,;-16.26,5.97,;-17.74,6.37,;-15.17,7.06,;-15.57,8.55,;-14.48,9.64,;-14.87,11.13,;-12.99,9.24,;-12.59,7.75,;-13.68,6.66,;-5.5,7.19,;-5.5,8.73,;-4.03,9.2,;-3.13,7.96,;-4.03,6.71,;-3.71,5.21,;4.29,5.21,;4.29,6.75,;5.62,7.52,;6.96,6.75,;6.96,5.21,;5.62,4.44,;8.29,7.52,;9.63,6.75,;9.63,5.21,;10.96,7.52,;12.29,8.29,;10.96,9.06,;12.21,9.96,;11.73,11.43,;10.19,11.43,;9.71,9.96,;12.29,6.75,;12.29,5.21,;13.76,4.73,;14.66,5.98,;13.76,7.22,;16.2,5.98,;16.97,7.31,;16.97,4.64,;17.74,5.98,)| InChI=1S/C45H54N6O6S2/c1-44(2,3)37-18-19-39(59-37)45(56,38-10-6-23-58-38)43(55)57-29-13-11-28(12-14-29)50(4)21-7-22-51-42-33-9-5-8-30(33)27(24-34(42)48-49-51)25-46-26-36(53)31-15-17-35(52)41-32(31)16-20-40(54)47-41/h6,10,15-20,23-24,28-29,36,46,52-53,56H,5,7-9,11-14,21-22,25-26H2,1-4H3,(H,47,54) WKRCJMIFYOLWFQ-UHFFFAOYSA-N 624879 US20230322745, Compound 5 Muscarinic acetylcholine receptor M3 Homo sapiens 13.8 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624879&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422809 485207246 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332438 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1ccc(s1)C(C)(C)C |r,wU:34.38,wD:14.14,37.45,(2.96,2.9,;2.96,4.44,;1.62,5.21,;.29,4.44,;-1.04,5.21,;-2.38,4.44,;-2.7,2.93,;-4.23,2.77,;-4.86,4.18,;-6.32,4.65,;-6.64,6.16,;-8.13,6.56,;-9.22,5.47,;-10.7,5.87,;-11.79,4.78,;-11.39,3.29,;-13.28,5.18,;-14.37,4.09,;-15.86,4.49,;-16.26,5.97,;-17.74,6.37,;-15.17,7.06,;-15.57,8.55,;-14.48,9.64,;-14.87,11.13,;-12.99,9.24,;-12.59,7.75,;-13.68,6.66,;-5.5,7.19,;-5.5,8.73,;-4.03,9.2,;-3.13,7.96,;-4.03,6.71,;-3.71,5.21,;4.29,5.21,;4.29,6.75,;5.62,7.52,;6.96,6.75,;6.96,5.21,;5.62,4.44,;8.29,7.52,;9.63,6.75,;9.63,5.21,;10.96,7.52,;12.29,8.29,;10.96,9.06,;12.21,9.96,;11.73,11.43,;10.19,11.43,;9.71,9.96,;12.29,6.75,;12.29,5.21,;13.76,4.73,;14.66,5.98,;13.76,7.22,;16.2,5.98,;16.97,7.31,;16.97,4.64,;17.74,5.98,)| InChI=1S/C45H54N6O6S2/c1-44(2,3)37-18-19-39(59-37)45(56,38-10-6-23-58-38)43(55)57-29-13-11-28(12-14-29)50(4)21-7-22-51-42-33-9-5-8-30(33)27(24-34(42)48-49-51)25-46-26-36(53)31-15-17-35(52)41-32(31)16-20-40(54)47-41/h6,10,15-20,23-24,28-29,36,46,52-53,56H,5,7-9,11-14,21-22,25-26H2,1-4H3,(H,47,54) WKRCJMIFYOLWFQ-UHFFFAOYSA-N 624908 US20230322745, Compound 6 Muscarinic acetylcholine receptor M3 Homo sapiens 3.86 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624908 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624908&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422812 485207275 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332439 O[C@@H](CNCc1cc2nnn(CCCN3CCC(CC3)OC(=O)C(O)(c3ccc(Cl)s3)c3ccc(Cl)s3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C39H40Cl2N6O6S2/c40-33-10-8-31(54-33)39(52,32-9-11-34(41)55-32)38(51)53-23-13-17-46(18-14-23)15-2-16-47-37-27-4-1-3-24(27)22(19-28(37)44-45-47)20-42-21-30(49)25-5-7-29(48)36-26(25)6-12-35(50)43-36/h5-12,19,23,30,42,48-49,52H,1-4,13-18,20-21H2,(H,43,50) ZWEQPUCUKAQJDM-UHFFFAOYSA-N 624974 US20230322745, Compound 7 Muscarinic acetylcholine receptor M3 Homo sapiens 5.57 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624974 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624974&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422864 485207340 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332440 O[C@@H](CNCc1cc2nnn(CCCN3CCC(CC3)OC(=O)[C@](O)(c3cccs3)c3ccc(Br)s3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C39H41BrN6O6S2/c40-34-11-10-33(54-34)39(51,32-6-2-19-53-32)38(50)52-24-13-17-45(18-14-24)15-3-16-46-37-28-5-1-4-25(28)23(20-29(37)43-44-46)21-41-22-31(48)26-7-9-30(47)36-27(26)8-12-35(49)42-36/h2,6-12,19-20,24,31,41,47-48,51H,1,3-5,13-18,21-22H2,(H,42,49) AWTNFLSDGKDYCY-UHFFFAOYSA-N 624910 US20230322745, Compound 8 Muscarinic acetylcholine receptor M3 Homo sapiens 2.77 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624910 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624910&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422813 485207277 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332441 O[C@@H](CNCc1cc2nnn(CCCN3CCC(CC3)OC(=O)C(O)(c3cccs3)c3ccc(Br)s3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C39H41BrN6O6S2/c40-34-11-10-33(54-34)39(51,32-6-2-19-53-32)38(50)52-24-13-17-45(18-14-24)15-3-16-46-37-28-5-1-4-25(28)23(20-29(37)43-44-46)21-41-22-31(48)26-7-9-30(47)36-27(26)8-12-35(49)42-36/h2,6-12,19-20,24,31,41,47-48,51H,1,3-5,13-18,21-22H2,(H,42,49) AWTNFLSDGKDYCY-UHFFFAOYSA-N 624912 US20230322745, Compound 9 Muscarinic acetylcholine receptor M3 Homo sapiens 4.16 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624912 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624912&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422815 485207279 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332442 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1ccc(Cl)s1)c1ccc(Cl)s1 |r,wU:34.38,wD:14.14,37.45,(3.95,-6.17,;4.35,-4.68,;3.26,-3.59,;1.77,-3.99,;.68,-2.9,;-.81,-3.3,;-1.43,-4.71,;-2.96,-4.55,;-3.28,-3.04,;-4.62,-2.27,;-4.62,-.73,;-5.95,.04,;-7.29,-.73,;-8.62,.04,;-9.95,-.73,;-9.95,-2.27,;-11.29,.04,;-12.62,-.73,;-13.95,.04,;-13.95,1.58,;-15.29,2.35,;-12.62,2.35,;-12.62,3.89,;-11.29,4.66,;-11.29,6.2,;-9.95,3.89,;-9.95,2.35,;-11.29,1.58,;-3.28,.04,;-2.96,1.55,;-1.43,1.71,;-.81,.3,;-1.95,-.73,;-1.95,-2.27,;5.83,-4.28,;6.23,-2.8,;7.72,-2.4,;8.81,-3.49,;8.41,-4.97,;6.92,-5.37,;10.3,-3.09,;10.7,-1.6,;9.61,-.51,;12.18,-1.2,;13.67,-.8,;12.58,.29,;11.68,1.53,;12.58,2.78,;14.05,2.3,;15.13,3.39,;14.05,.76,;13.27,-2.29,;14.81,-2.29,;15.29,-3.75,;14.04,-4.66,;14.04,-6.2,;12.8,-3.75,)| InChI=1S/C41H44Cl2N6O6S2/c1-48(24-6-8-25(9-7-24)55-40(53)41(54,33-13-15-35(42)56-33)34-14-16-36(43)57-34)18-3-19-49-39-29-5-2-4-26(29)23(20-30(39)46-47-49)21-44-22-32(51)27-10-12-31(50)38-28(27)11-17-37(52)45-38/h10-17,20,24-25,32,44,50-51,54H,2-9,18-19,21-22H2,1H3,(H,45,52) FLAAUKBTPUMXAW-UHFFFAOYSA-N 624943 US20230322745, Compound 10 Muscarinic acetylcholine receptor M3 Homo sapiens 1.27 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624943 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624943&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422834 485207310 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332443 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3cnn(C)c3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wU:35.39,wD:38.46,14.14,(4.5,-4.2,;4.5,-2.66,;3.16,-1.89,;1.83,-2.66,;.5,-1.89,;-.84,-2.66,;-1.16,-4.17,;-2.69,-4.33,;-3.32,-2.92,;-4.78,-2.45,;-5.1,-.94,;-6.59,-.54,;-7.68,-1.63,;-9.16,-1.23,;-10.25,-2.32,;-9.85,-3.81,;-11.74,-1.92,;-12.83,-3.01,;-14.32,-2.61,;-14.72,-1.12,;-16.2,-.73,;-13.63,-.04,;-14.03,1.45,;-12.94,2.54,;-13.33,4.03,;-11.45,2.14,;-11.05,.65,;-12.14,-.43,;-3.96,.09,;-3.96,1.63,;-2.49,2.11,;-1.59,.86,;-.05,.86,;-2.49,-.38,;-2.17,-1.89,;5.83,-1.89,;5.83,-.35,;7.16,.42,;8.5,-.35,;8.5,-1.89,;7.16,-2.66,;9.83,.42,;11.17,-.35,;11.17,-1.89,;12.5,.42,;13.83,1.19,;13.83,-.35,;13.83,-1.89,;15.3,-2.37,;16.2,-1.12,;15.3,.12,;12.5,1.96,;13.75,2.86,;13.27,4.33,;11.73,4.33,;11.25,2.86,)| InChI=1S/C40H44N8O6S2/c1-46(25-8-10-26(11-9-25)54-39(52)40(53,33-6-3-18-55-33)34-7-4-19-56-34)16-5-17-48-38-30(44-45-48)20-24(29-22-42-47(2)37(29)38)21-41-23-32(50)27-12-14-31(49)36-28(27)13-15-35(51)43-36/h3-4,6-7,12-15,18-20,22,25-26,32,41,49-50,53H,5,8-11,16-17,21,23H2,1-2H3,(H,43,51) GJLQIWOFIGFHLI-UHFFFAOYSA-N 624944 US20230322745, Compound 11 Muscarinic acetylcholine receptor M3 Homo sapiens 0.638 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624944&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422835 485207311 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332444 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C42H48N6O6S2/c1-25-9-17-37(56-25)42(53,36-8-4-21-55-36)41(52)54-28-12-10-27(11-13-28)47(2)19-5-20-48-40-32-7-3-6-29(32)26(22-33(40)45-46-48)23-43-24-35(50)30-14-16-34(49)39-31(30)15-18-38(51)44-39/h4,8-9,14-18,21-22,27-28,35,43,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,44,51) BDWSAAGKPWOYAA-UHFFFAOYSA-N 624946 US20230322745, Compound 13 Muscarinic acetylcholine receptor M3 Homo sapiens 0.687 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624946 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624946&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422837 485207313 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332445 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1ccc(C)s1 |r,wU:34.38,wD:14.14,37.45,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C42H48N6O6S2/c1-25-9-17-37(56-25)42(53,36-8-4-21-55-36)41(52)54-28-12-10-27(11-13-28)47(2)19-5-20-48-40-32-7-3-6-29(32)26(22-33(40)45-46-48)23-43-24-35(50)30-14-16-34(49)39-31(30)15-18-38(51)44-39/h4,8-9,14-18,21-22,27-28,35,43,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,44,51) BDWSAAGKPWOYAA-UHFFFAOYSA-N 624947 US20230322745, Compound 14 Muscarinic acetylcholine receptor M3 Homo sapiens 0.661 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624947&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422838 485207314 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332446 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Br)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C41H45BrN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) RAXKPRMYCBJHGZ-UHFFFAOYSA-N 624948 US20230322745, Compound 16::US20230322745, Compound 15 Muscarinic acetylcholine receptor M3 Homo sapiens 0.198 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624948&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422839 485207315 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332447 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Br)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C41H45BrN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) RAXKPRMYCBJHGZ-UHFFFAOYSA-N 624948 US20230322745, Compound 16::US20230322745, Compound 15 Muscarinic acetylcholine receptor M3 Homo sapiens 0.255 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624948&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422839 485207315 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332448 O[C@@H](CNCc1cc2nnn(CCCN3CC4(CC(C4)OC(=O)[C@](O)(c4cccs4)c4ccc(s4)-c4ccccc4)C3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C46H46N6O6S2/c53-36-14-12-32(33-13-17-41(55)48-42(33)36)37(54)25-47-24-29-21-35-43(34-10-4-9-31(29)34)52(50-49-35)19-6-18-51-26-45(27-51)22-30(23-45)58-44(56)46(57,39-11-5-20-59-39)40-16-15-38(60-40)28-7-2-1-3-8-28/h1-3,5,7-8,11-17,20-21,30,37,47,53-54,57H,4,6,9-10,18-19,22-27H2,(H,48,55) CCGIPFMUSYPUHM-UHFFFAOYSA-N 624975 US20230322745, Compound 18 Muscarinic acetylcholine receptor M3 Homo sapiens 9.36 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624975 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624975&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422865 485207341 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332449 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(CC(C4)OC(=O)C(O)(c4ccc(Cl)s4)c4ccc(Cl)s4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H44Cl2N6O6S2/c43-35-10-8-33(57-35)42(55,34-9-11-36(44)58-34)40(54)56-25-20-41(21-25)13-17-49(18-14-41)15-2-16-50-39-29-4-1-3-26(29)24(19-30(39)47-48-50)22-45-23-32(52)27-5-7-31(51)38-28(27)6-12-37(53)46-38/h5-12,19,25,32,45,51-52,55H,1-4,13-18,20-23H2,(H,46,53) SRFLTTOQPVNVGB-UHFFFAOYSA-N 624950 US20230322745, Compound 19 Muscarinic acetylcholine receptor M3 Homo sapiens 0.281 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624950 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624950&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422840 485207316 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332450 O[C@@H](CNCc1cc2nnn(CCCN3CC4(CC(C4)OC(=O)[C@@](O)(c4cccs4)c4cc5ccccc5s4)C3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C44H44N6O6S2/c51-34-13-11-30(31-12-14-39(53)46-40(31)34)35(52)23-45-22-27-18-33-41(32-8-3-7-29(27)32)50(48-47-33)16-5-15-49-24-43(25-49)20-28(21-43)56-42(54)44(55,37-10-4-17-57-37)38-19-26-6-1-2-9-36(26)58-38/h1-2,4,6,9-14,17-19,28,35,45,51-52,55H,3,5,7-8,15-16,20-25H2,(H,46,53) XLLKIFCSOJPTBQ-UHFFFAOYSA-N 624976 US20230322745, Compound 20 Muscarinic acetylcholine receptor M3 Homo sapiens 31.1 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624976&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422866 485207342 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332451 O[C@@H](CNCc1cc2nnn(CCCN3CC4(CC(C4)OC(=O)C(O)(c4cccs4)c4cc5ccccc5s4)C3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C44H44N6O6S2/c51-34-13-11-30(31-12-14-39(53)46-40(31)34)35(52)23-45-22-27-18-33-41(32-8-3-7-29(27)32)50(48-47-33)16-5-15-49-24-43(25-49)20-28(21-43)56-42(54)44(55,37-10-4-17-57-37)38-19-26-6-1-2-9-36(26)58-38/h1-2,4,6,9-14,17-19,28,35,45,51-52,55H,3,5,7-8,15-16,20-25H2,(H,46,53) XLLKIFCSOJPTBQ-UHFFFAOYSA-N 624951 US20230322745, Compound 21 Muscarinic acetylcholine receptor M3 Homo sapiens 1.53 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624951 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624951&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422841 485207317 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332452 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(C[C@H](CO4)OC(=O)C(O)(c4cccs4)c4cccs4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O7S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)24-43-23-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)16-4-15-47-17-13-41(14-18-47)22-27(25-54-41)55-40(52)42(53,35-7-2-19-56-35)36-8-3-20-57-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) OYKGMOVRDZQXJB-UHFFFAOYSA-N 624953 US20230322745, Compound 24 Muscarinic acetylcholine receptor M3 Homo sapiens 0.220 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624953 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624953&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422843 485207319 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332453 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(C[C@@H](CO4)OC(=O)C(O)(c4cccs4)c4cccs4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O7S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)24-43-23-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)16-4-15-47-17-13-41(14-18-47)22-27(25-54-41)55-40(52)42(53,35-7-2-19-56-35)36-8-3-20-57-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) OYKGMOVRDZQXJB-UHFFFAOYSA-N 624955 US20230322745, Compound 25 Muscarinic acetylcholine receptor M3 Homo sapiens 0.179 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624955 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624955&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422845 485207321 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332454 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Cl)s1 |r,wU:37.45,43.49,wD:14.14,43.50,(3.77,3.25,;4.17,4.74,;3.08,5.83,;1.59,5.43,;.5,6.52,;-.98,6.12,;-1.61,4.72,;-3.14,4.88,;-3.46,6.38,;-4.8,7.15,;-4.8,8.69,;-6.13,9.46,;-7.46,8.69,;-8.8,9.46,;-10.13,8.69,;-10.13,7.15,;-11.46,9.46,;-12.8,8.69,;-14.13,9.46,;-14.13,11,;-15.46,11.77,;-12.8,11.77,;-12.8,13.31,;-11.46,14.08,;-11.46,15.62,;-10.13,13.31,;-10.13,11.77,;-11.46,11,;-3.46,9.46,;-3.14,10.97,;-1.61,11.13,;-.98,9.72,;-2.13,8.69,;-2.13,7.15,;5.66,5.14,;6.75,4.05,;8.23,4.45,;8.63,5.94,;7.54,7.03,;6.06,6.63,;10.12,6.34,;10.52,7.82,;9.43,8.91,;12.01,8.22,;13.49,8.62,;12.4,9.71,;11.44,10.91,;12.27,12.2,;13.76,11.8,;13.84,10.26,;13.09,7.13,;14.56,7.61,;15.46,6.36,;14.56,5.12,;15.04,3.65,;13.09,5.59,)| InChI=1S/C41H45ClN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) CZFARYRCUMIUSD-UHFFFAOYSA-N 624956 US20230322745, Compound 28 Muscarinic acetylcholine receptor M3 Homo sapiens 0.136 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624956&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422846 485207322 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332455 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(Cl)s1 |r,wU:37.45,43.50,wD:14.14,43.49,(3.77,3.25,;4.17,4.74,;3.08,5.83,;1.59,5.43,;.5,6.52,;-.98,6.12,;-1.61,4.72,;-3.14,4.88,;-3.46,6.38,;-4.8,7.15,;-4.8,8.69,;-6.13,9.46,;-7.46,8.69,;-8.8,9.46,;-10.13,8.69,;-10.13,7.15,;-11.46,9.46,;-12.8,8.69,;-14.13,9.46,;-14.13,11,;-15.46,11.77,;-12.8,11.77,;-12.8,13.31,;-11.46,14.08,;-11.46,15.62,;-10.13,13.31,;-10.13,11.77,;-11.46,11,;-3.46,9.46,;-3.14,10.97,;-1.61,11.13,;-.98,9.72,;-2.13,8.69,;-2.13,7.15,;5.66,5.14,;6.75,4.05,;8.23,4.45,;8.63,5.94,;7.54,7.03,;6.06,6.63,;10.12,6.34,;10.52,7.82,;9.43,8.91,;12.01,8.22,;13.49,8.62,;12.4,9.71,;11.44,10.91,;12.27,12.2,;13.76,11.8,;13.84,10.26,;13.09,7.13,;14.56,7.61,;15.46,6.36,;14.56,5.12,;15.04,3.65,;13.09,5.59,)| InChI=1S/C41H45ClN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) CZFARYRCUMIUSD-UHFFFAOYSA-N 624957 US20230322745, Compound 29 Muscarinic acetylcholine receptor M3 Homo sapiens 0.324 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624957 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624957&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422847 485207323 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332456 C[N+]1(CCCn2nnc3cc(CNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)c4CCCc4c23)CCC(CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,(3.8,.2,;5.14,.97,;3.67,1.44,;2.53,.41,;1.06,.89,;-.08,-.14,;.08,-1.67,;-1.33,-2.3,;-2.36,-1.16,;-3.9,-1.16,;-4.67,.18,;-6.21,.18,;-6.98,-1.16,;-8.52,-1.16,;-9.29,-2.49,;-8.52,-3.82,;-10.83,-2.49,;-11.6,-3.82,;-13.14,-3.82,;-13.91,-2.49,;-15.45,-2.49,;-13.14,-1.16,;-13.91,.18,;-13.14,1.51,;-13.91,2.85,;-11.6,1.51,;-10.83,.18,;-11.6,-1.16,;-3.9,1.51,;-4.37,2.98,;-3.13,3.88,;-1.88,2.98,;-2.36,1.51,;-1.59,.18,;5.46,-.54,;6.92,-1.02,;8.07,.02,;7.75,1.52,;6.28,2,;9.53,-.46,;10.67,.57,;10.35,2.08,;12.14,.09,;13.63,-.3,;13.23,1.18,;12.99,2.7,;14.36,3.4,;15.45,2.31,;14.75,.94,;12.54,-1.39,;13.98,-1.95,;13.89,-3.48,;12.41,-3.88,;11.57,-2.59,)| InChI=1S/C40H44N6O6S2/c1-46(18-14-26(15-19-46)52-39(50)40(51,34-8-3-20-53-34)35-9-4-21-54-35)17-5-16-45-38-30-7-2-6-27(30)25(22-31(38)43-44-45)23-41-24-33(48)28-10-12-32(47)37-29(28)11-13-36(49)42-37/h3-4,8-13,20-22,26,33,41,48,51H,2,5-7,14-19,23-24H2,1H3,(H-,42,43,44,47,49)/p+1 IEFAHOCPMRQNBE-UHFFFAOYSA-O 624958 US20230322745, Compound 30 Muscarinic acetylcholine receptor M3 Homo sapiens 1.10 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624958 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624958&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422848 485207324 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332457 O[C@@H](CNCc1cc2nnn(CCCN3CCC(O)(COC(=O)C(O)(c4cccs4)c4cccs4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C40H44N6O7S2/c47-31-11-9-27(28-10-12-35(49)42-36(28)31)32(48)23-41-22-25-21-30-37(29-6-1-5-26(25)29)46(44-43-30)16-4-15-45-17-13-39(51,14-18-45)24-53-38(50)40(52,33-7-2-19-54-33)34-8-3-20-55-34/h2-3,7-12,19-21,32,41,47-48,51-52H,1,4-6,13-18,22-24H2,(H,42,49) HJDHZGJLXLKQPN-UHFFFAOYSA-N 624977 US20230322745, Compound 31 Muscarinic acetylcholine receptor M3 Homo sapiens 0.655 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624977 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624977&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422867 485207343 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332458 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@H](CC(=O)C(O)(c2ccc(C)s2)c2ccc(C)s2)CC1 |r,wU:34.38,wD:14.14,37.42,(4.51,-4.78,;4.51,-3.24,;3.17,-2.47,;1.84,-3.24,;.5,-2.47,;-.83,-3.24,;-1.07,-4.76,;-2.59,-5,;-3.29,-3.63,;-4.78,-3.23,;-5.18,-1.74,;-6.66,-1.34,;-7.75,-2.43,;-9.24,-2.03,;-10.33,-3.12,;-9.93,-4.61,;-11.82,-2.72,;-12.91,-3.81,;-14.39,-3.41,;-14.79,-1.93,;-16.28,-1.53,;-13.7,-.84,;-14.1,.65,;-13.01,1.74,;-13.41,3.23,;-11.52,1.34,;-11.13,-.15,;-12.22,-1.24,;-4.09,-.65,;-4.17,.89,;-2.73,1.44,;-1.76,.24,;-2.6,-1.05,;-2.2,-2.54,;5.84,-2.47,;5.84,-.93,;7.17,-.16,;8.51,-.93,;9.84,-.16,;11.17,-.93,;11.17,-2.47,;12.51,-.16,;13.84,.61,;13.84,-.93,;15.25,-.3,;16.28,-1.44,;15.51,-2.78,;16.14,-4.19,;14,-2.46,;12.51,1.38,;11.26,2.29,;11.74,3.75,;13.28,3.75,;14.18,5,;13.75,2.29,;8.51,-2.47,;7.17,-3.24,)| InChI=1S/C44H52N6O5S2/c1-26-8-17-39(56-26)44(55,40-18-9-27(2)57-40)38(53)22-28-10-12-30(13-11-28)49(3)20-5-21-50-43-34-7-4-6-31(34)29(23-35(43)47-48-50)24-45-25-37(52)32-14-16-36(51)42-33(32)15-19-41(54)46-42/h8-9,14-19,23,28,30,37,45,51-52,55H,4-7,10-13,20-22,24-25H2,1-3H3,(H,46,54) JSDLJSSEKWSNAT-UHFFFAOYSA-N 624959 US20230322745, Compound 32 Muscarinic acetylcholine receptor M3 Homo sapiens 1.20 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624959&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422849 485207325 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332459 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C39H42N6O8S2/c1-44(24-7-9-25(10-8-24)53-38(49)39(50,31-5-2-17-54-31)32-6-3-18-55-32)15-4-16-45-35-28(42-43-45)19-23(36-37(35)52-22-51-36)20-40-21-30(47)26-11-13-29(46)34-27(26)12-14-33(48)41-34/h2-3,5-6,11-14,17-19,24-25,30,40,46-47,50H,4,7-10,15-16,20-22H2,1H3,(H,41,48) ZYYNDNILFMUVTL-UHFFFAOYSA-N 624960 US20230322745, Compound 33 Muscarinic acetylcholine receptor M3 Homo sapiens 0.494 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624960&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422850 485207326 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332460 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,1.47,;4.17,2.96,;3.08,4.04,;1.59,3.65,;.5,4.73,;-.98,4.34,;-1.61,2.93,;-3.14,3.09,;-3.46,4.6,;-4.8,5.37,;-4.8,6.91,;-6.13,7.68,;-7.46,6.91,;-8.8,7.68,;-10.13,6.91,;-10.13,5.37,;-11.46,7.68,;-12.8,6.91,;-14.13,7.68,;-14.13,9.22,;-15.46,9.99,;-12.8,9.99,;-12.8,11.53,;-11.46,12.3,;-11.46,13.84,;-10.13,11.53,;-10.13,9.99,;-11.46,9.22,;-3.46,7.68,;-3.14,9.18,;-1.61,9.34,;-.98,7.94,;-2.13,6.91,;-2.13,5.37,;5.66,3.35,;6.06,4.84,;7.54,5.24,;8.63,4.15,;8.23,2.66,;6.75,2.26,;10.12,4.55,;10.52,6.04,;9.43,7.13,;12.01,6.44,;13.49,6.83,;12.4,7.92,;11.44,9.12,;12.27,10.41,;13.76,10.01,;13.84,8.47,;13.09,5.35,;14.56,5.82,;15.46,4.58,;14.56,3.33,;15.04,1.87,;13.09,3.81,)| InChI=1S/C40H44N6O8S2/c1-23-6-14-33(56-23)40(51,32-5-3-18-55-32)39(50)54-26-9-7-25(8-10-26)45(2)16-4-17-46-36-29(43-44-46)19-24(37-38(36)53-22-52-37)20-41-21-31(48)27-11-13-30(47)35-28(27)12-15-34(49)42-35/h3,5-6,11-15,18-19,25-26,31,41,47-48,51H,4,7-10,16-17,20-22H2,1-2H3,(H,42,49) FYYWKHFZJYSOCA-UHFFFAOYSA-N 624961 US20230322745, Compound 34 Muscarinic acetylcholine receptor M3 Homo sapiens 0.657 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624961 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624961&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422851 485207327 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332461 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,1.47,;4.17,2.96,;3.08,4.04,;1.59,3.65,;.5,4.73,;-.98,4.34,;-1.61,2.93,;-3.14,3.09,;-3.46,4.6,;-4.8,5.37,;-4.8,6.91,;-6.13,7.68,;-7.46,6.91,;-8.8,7.68,;-10.13,6.91,;-10.13,5.37,;-11.46,7.68,;-12.8,6.91,;-14.13,7.68,;-14.13,9.22,;-15.46,9.99,;-12.8,9.99,;-12.8,11.53,;-11.46,12.3,;-11.46,13.84,;-10.13,11.53,;-10.13,9.99,;-11.46,9.22,;-3.46,7.68,;-3.14,9.18,;-1.61,9.34,;-.98,7.94,;-2.13,6.91,;-2.13,5.37,;5.66,3.35,;6.06,4.84,;7.54,5.24,;8.63,4.15,;8.23,2.66,;6.75,2.26,;10.12,4.55,;10.52,6.04,;9.43,7.13,;12.01,6.44,;13.49,6.83,;12.4,7.92,;11.44,9.12,;12.27,10.41,;13.76,10.01,;13.84,8.47,;13.09,5.35,;14.56,5.82,;15.46,4.58,;14.56,3.33,;15.04,1.87,;13.09,3.81,)| InChI=1S/C40H44N6O8S2/c1-23-6-14-33(56-23)40(51,32-5-3-18-55-32)39(50)54-26-9-7-25(8-10-26)45(2)16-4-17-46-36-29(43-44-46)19-24(37-38(36)53-22-52-37)20-41-21-31(48)27-11-13-30(47)35-28(27)12-15-34(49)42-35/h3,5-6,11-15,18-19,25-26,31,41,47-48,51H,4,7-10,16-17,20-22H2,1-2H3,(H,42,49) FYYWKHFZJYSOCA-UHFFFAOYSA-N 624962 US20230322745, Compound 35 Muscarinic acetylcholine receptor M3 Homo sapiens 0.213 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624962&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422852 485207328 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332462 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,.8,;4.17,2.29,;3.08,3.38,;1.59,2.98,;.5,4.07,;-.98,3.67,;-1.61,2.26,;-3.14,2.42,;-3.46,3.93,;-4.8,4.7,;-4.8,6.24,;-6.13,7.01,;-7.46,6.24,;-8.8,7.01,;-10.13,6.24,;-10.13,4.7,;-11.46,7.01,;-12.8,6.24,;-14.13,7.01,;-14.13,8.55,;-15.46,9.32,;-12.8,9.32,;-12.8,10.86,;-11.46,11.63,;-11.46,13.17,;-10.13,10.86,;-10.13,9.32,;-11.46,8.55,;-3.46,7.01,;-3.14,8.51,;-1.61,8.68,;-.98,7.27,;-2.13,6.24,;-2.13,4.7,;5.66,2.69,;6.06,4.17,;7.54,4.57,;8.63,3.48,;8.23,2,;6.75,1.6,;10.12,3.88,;10.52,5.37,;9.43,6.46,;12.01,5.77,;13.49,6.17,;12.4,7.26,;11.44,8.45,;12.27,9.74,;13.76,9.35,;13.84,7.81,;13.09,4.68,;14.56,5.15,;15.46,3.91,;14.56,2.66,;15.04,1.2,;13.09,3.14,)| InChI=1S/C41H46N6O7S2/c1-24-6-14-36(56-24)41(52,35-5-3-18-55-35)40(51)54-27-9-7-26(8-10-27)46(2)16-4-17-47-39-31-23-53-22-30(31)25(19-32(39)44-45-47)20-42-21-34(49)28-11-13-33(48)38-29(28)12-15-37(50)43-38/h3,5-6,11-15,18-19,26-27,34,42,48-49,52H,4,7-10,16-17,20-23H2,1-2H3,(H,43,50) ITYRYCDVBXJIPH-UHFFFAOYSA-N 624963 US20230322745, Compound 36 Muscarinic acetylcholine receptor M3 Homo sapiens 0.792 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624963 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624963&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422853 485207329 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332463 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,.8,;4.17,2.29,;3.08,3.38,;1.59,2.98,;.5,4.07,;-.98,3.67,;-1.61,2.26,;-3.14,2.42,;-3.46,3.93,;-4.8,4.7,;-4.8,6.24,;-6.13,7.01,;-7.46,6.24,;-8.8,7.01,;-10.13,6.24,;-10.13,4.7,;-11.46,7.01,;-12.8,6.24,;-14.13,7.01,;-14.13,8.55,;-15.46,9.32,;-12.8,9.32,;-12.8,10.86,;-11.46,11.63,;-11.46,13.17,;-10.13,10.86,;-10.13,9.32,;-11.46,8.55,;-3.46,7.01,;-3.14,8.51,;-1.61,8.68,;-.98,7.27,;-2.13,6.24,;-2.13,4.7,;5.66,2.69,;6.06,4.17,;7.54,4.57,;8.63,3.48,;8.23,2,;6.75,1.6,;10.12,3.88,;10.52,5.37,;9.43,6.46,;12.01,5.77,;13.49,6.17,;12.4,7.26,;11.44,8.45,;12.27,9.74,;13.76,9.35,;13.84,7.81,;13.09,4.68,;14.56,5.15,;15.46,3.91,;14.56,2.66,;15.04,1.2,;13.09,3.14,)| InChI=1S/C41H46N6O7S2/c1-24-6-14-36(56-24)41(52,35-5-3-18-55-35)40(51)54-27-9-7-26(8-10-27)46(2)16-4-17-47-39-31-23-53-22-30(31)25(19-32(39)44-45-47)20-42-21-34(49)28-11-13-33(48)38-29(28)12-15-37(50)43-38/h3,5-6,11-15,18-19,26-27,34,42,48-49,52H,4,7-10,16-17,20-23H2,1-2H3,(H,43,50) ITYRYCDVBXJIPH-UHFFFAOYSA-N 624964 US20230322745, Compound 37 Muscarinic acetylcholine receptor M3 Homo sapiens 0.871 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624964&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422854 485207330 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332464 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,1.68,;4.17,3.17,;3.08,4.26,;1.59,3.86,;.5,4.95,;-.98,4.55,;-1.61,3.15,;-3.14,3.31,;-3.46,4.81,;-4.8,5.58,;-4.8,7.12,;-6.13,7.89,;-7.46,7.12,;-8.8,7.89,;-10.13,7.12,;-10.13,5.58,;-11.46,7.89,;-12.8,7.12,;-14.13,7.89,;-14.13,9.43,;-15.46,10.2,;-12.8,10.2,;-12.8,11.74,;-11.46,12.51,;-11.46,14.05,;-10.13,11.74,;-10.13,10.2,;-11.46,9.43,;-3.46,7.89,;-3.14,9.4,;-1.61,9.56,;-.98,8.15,;-2.13,7.12,;-2.13,5.58,;5.66,3.57,;6.06,5.06,;7.54,5.46,;8.63,4.37,;8.23,2.88,;6.75,2.48,;10.12,4.77,;10.52,6.25,;9.43,7.34,;12.01,6.65,;13.49,7.05,;12.4,8.14,;11.44,9.34,;12.27,10.63,;13.76,10.23,;13.84,8.69,;13.09,5.56,;14.56,6.04,;15.46,4.79,;14.56,3.55,;15.04,2.08,;13.09,4.02,)| InChI=1S/C43H49N5O6S2/c1-26-9-17-38(56-26)43(53,37-8-4-21-55-37)42(52)54-29-12-10-28(11-13-29)47(2)19-5-20-48-25-45-34-22-27(30-6-3-7-33(30)41(34)48)23-44-24-36(50)31-14-16-35(49)40-32(31)15-18-39(51)46-40/h4,8-9,14-18,21-22,25,28-29,36,44,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,46,51) UBDKDGUJMUUUTQ-UHFFFAOYSA-N 624965 US20230322745, Compound 38 Muscarinic acetylcholine receptor M3 Homo sapiens 0.555 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624965&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422855 485207331 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332465 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,1.68,;4.17,3.17,;3.08,4.26,;1.59,3.86,;.5,4.95,;-.98,4.55,;-1.61,3.15,;-3.14,3.31,;-3.46,4.81,;-4.8,5.58,;-4.8,7.12,;-6.13,7.89,;-7.46,7.12,;-8.8,7.89,;-10.13,7.12,;-10.13,5.58,;-11.46,7.89,;-12.8,7.12,;-14.13,7.89,;-14.13,9.43,;-15.46,10.2,;-12.8,10.2,;-12.8,11.74,;-11.46,12.51,;-11.46,14.05,;-10.13,11.74,;-10.13,10.2,;-11.46,9.43,;-3.46,7.89,;-3.14,9.4,;-1.61,9.56,;-.98,8.15,;-2.13,7.12,;-2.13,5.58,;5.66,3.57,;6.06,5.06,;7.54,5.46,;8.63,4.37,;8.23,2.88,;6.75,2.48,;10.12,4.77,;10.52,6.25,;9.43,7.34,;12.01,6.65,;13.49,7.05,;12.4,8.14,;11.44,9.34,;12.27,10.63,;13.76,10.23,;13.84,8.69,;13.09,5.56,;14.56,6.04,;15.46,4.79,;14.56,3.55,;15.04,2.08,;13.09,4.02,)| InChI=1S/C43H49N5O6S2/c1-26-9-17-38(56-26)43(53,37-8-4-21-55-37)42(52)54-29-12-10-28(11-13-29)47(2)19-5-20-48-25-45-34-22-27(30-6-3-7-33(30)41(34)48)23-44-24-36(50)31-14-16-35(49)40-32(31)15-18-39(51)46-40/h4,8-9,14-18,21-22,25,28-29,36,44,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,46,51) UBDKDGUJMUUUTQ-UHFFFAOYSA-N 624966 US20230322745, Compound 39 Muscarinic acetylcholine receptor M3 Homo sapiens 0.533 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624966&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422856 485207332 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332466 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C40H44N6O7S2/c1-45(25-7-9-26(10-8-25)53-39(50)40(51,34-5-2-17-54-34)35-6-3-18-55-35)15-4-16-46-38-30-23-52-22-29(30)24(19-31(38)43-44-46)20-41-21-33(48)27-11-13-32(47)37-28(27)12-14-36(49)42-37/h2-3,5-6,11-14,17-19,25-26,33,41,47-48,51H,4,7-10,15-16,20-23H2,1H3,(H,42,49) NTARVXTWEZJQNE-UHFFFAOYSA-N 624967 US20230322745, Compound 40 Muscarinic acetylcholine receptor M3 Homo sapiens 0.363 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624967 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624967&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422857 485207333 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332467 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C42H47N5O6S2/c1-46(27-10-12-28(13-11-27)53-41(51)42(52,36-8-3-20-54-36)37-9-4-21-55-37)18-5-19-47-25-44-33-22-26(29-6-2-7-32(29)40(33)47)23-43-24-35(49)30-14-16-34(48)39-31(30)15-17-38(50)45-39/h3-4,8-9,14-17,20-22,25,27-28,35,43,48-49,52H,2,5-7,10-13,18-19,23-24H2,1H3,(H,45,50) UFQHICFQEIEWLF-UHFFFAOYSA-N 624969 US20230322745, Compound 41 Muscarinic acetylcholine receptor M3 Homo sapiens 0.201 US Patent 10.7270/Q2T157SH aid1919842 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5682&target=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624969&enzyme=Muscarinic+acetylcholine+receptor+M3&column=ki&startPg=0&Increment=50&submit=Search 169422859 485207335 1 MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL 8E9W,8EA0,8E9Z,8E9Y Muscarinic acetylcholine receptor M3 ACM3_HUMAN P20309 Q0VAJ8 Q4QRI3 Q5VXY2 Q9HB60 1332468 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wU:34.38,wD:37.45,14.14,(4.5,-4.2,;4.5,-2.66,;3.16,-1.89,;1.83,-2.66,;.5,-1.89,;-.84,-2.66,;-1.16,-4.17,;-2.69,-4.33,;-3.32,-2.92,;-4.78,-2.45,;-5.1,-.94,;-6.59,-.54,;-7.68,-1.63,;-9.16,-1.23,;-10.25,-2.32,;-9.85,-3.81,;-11.74,-1.92,;-12.83,-3.01,;-14.32,-2.61,;-14.72,-1.12,;-16.2,-.73,;-13.63,-.04,;-14.03,1.45,;-12.94,2.54,;-13.33,4.03,;-11.45,2.14,;-11.05,.65,;-12.14,-.43,;-3.96,.09,;-3.96,1.63,;-2.49,2.11,;-1.59,.86,;-2.49,-.38,;-2.17,-1.89,;5.83,-1.89,;5.83,-.35,;7.16,.42,;8.5,-.35,;8.5,-1.89,;7.16,-2.66,;9.83,.42,;11.17,-.35,;11.17,-1.89,;12.5,.42,;13.83,1.19,;13.83,-.35,;13.83,-1.89,;15.3,-2.37,;16.2,-1.12,;15.3,.12,;12.5,1.96,;13.75,2.86,;13.27,4.33,;11.73,4.33,;11.25,2.86,)| InChI=1S/C41H46N6O6S2/c1-46(26-10-12-27(13-11-26)53-40(51)41(52,35-8-3-20-54-35)36-9-4-21-55-36)18-5-19-47-39-31-7-2-6-28(31)25(22-32(39)44-45-47)23-42-24-34(49)29-14-16-33(48)38-30(29)15-17-37(50)43-38/h3-4,8-9,14-17,20-22,26-27,34,42,48-49,52H,2,5-7,10-13,18-19,23-24H2,1H3,(H,43,50) IBNSRKXSITXGAZ-UHFFFAOYSA-N 624859 US20230322745, Compound 1::US20250230148, Compound of formula (I) Muscarinic acetylcholine receptor M2 Homo sapiens 0.062 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624859&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422802 485207226 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332469 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C42H48N6O6S2/c1-25-9-17-37(56-25)42(53,36-8-4-21-55-36)41(52)54-28-12-10-27(11-13-28)47(2)19-5-20-48-40-32-7-3-6-29(32)26(22-33(40)45-46-48)23-43-24-35(50)30-14-16-34(49)39-31(30)15-18-38(51)44-39/h4,8-9,14-18,21-22,27-28,35,43,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,44,51) BDWSAAGKPWOYAA-UHFFFAOYSA-N 624946 US20230322745, Compound 13 Muscarinic acetylcholine receptor M2 Homo sapiens 0.240 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624946 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624946&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422837 485207313 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332470 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1ccc(C)s1 |r,wU:34.38,wD:14.14,37.45,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C42H48N6O6S2/c1-25-9-17-37(56-25)42(53,36-8-4-21-55-36)41(52)54-28-12-10-27(11-13-28)47(2)19-5-20-48-40-32-7-3-6-29(32)26(22-33(40)45-46-48)23-43-24-35(50)30-14-16-34(49)39-31(30)15-18-38(51)44-39/h4,8-9,14-18,21-22,27-28,35,43,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,44,51) BDWSAAGKPWOYAA-UHFFFAOYSA-N 624947 US20230322745, Compound 14 Muscarinic acetylcholine receptor M2 Homo sapiens 0.375 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624947&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422838 485207314 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332471 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Br)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C41H45BrN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) RAXKPRMYCBJHGZ-UHFFFAOYSA-N 624948 US20230322745, Compound 16::US20230322745, Compound 15 Muscarinic acetylcholine receptor M2 Homo sapiens 0.130 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624948&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422839 485207315 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332472 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Br)s1 |r,wU:34.38,43.49,wD:14.14,37.45,43.56,(4.5,4.18,;4.5,5.72,;3.16,6.49,;1.83,5.72,;.5,6.49,;-.84,5.72,;-1.16,4.21,;-2.69,4.05,;-3.32,5.46,;-4.78,5.93,;-5.1,7.44,;-6.59,7.84,;-7.68,6.75,;-9.16,7.15,;-10.25,6.06,;-9.85,4.57,;-11.74,6.46,;-12.83,5.37,;-14.32,5.77,;-14.72,7.26,;-16.2,7.65,;-13.63,8.34,;-14.03,9.83,;-12.94,10.92,;-13.33,12.41,;-11.45,10.52,;-11.05,9.03,;-12.14,7.95,;-3.96,8.47,;-3.96,10.01,;-2.49,10.49,;-1.59,9.24,;-2.49,7.99,;-2.17,6.49,;5.83,6.49,;5.83,8.03,;7.16,8.8,;8.5,8.03,;8.5,6.49,;7.16,5.72,;9.83,8.8,;11.17,8.03,;11.17,6.49,;12.5,8.8,;13.83,9.57,;12.5,10.34,;11.25,11.24,;11.73,12.71,;13.27,12.71,;13.75,11.24,;13.83,8.03,;15.3,8.5,;16.2,7.26,;15.3,6.01,;15.7,4.53,;13.83,6.49,)| InChI=1S/C41H45BrN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) RAXKPRMYCBJHGZ-UHFFFAOYSA-N 624948 US20230322745, Compound 16::US20230322745, Compound 15 Muscarinic acetylcholine receptor M2 Homo sapiens 0.104 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624948&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422839 485207315 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332473 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(C[C@H](CO4)OC(=O)C(O)(c4cccs4)c4cccs4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O7S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)24-43-23-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)16-4-15-47-17-13-41(14-18-47)22-27(25-54-41)55-40(52)42(53,35-7-2-19-56-35)36-8-3-20-57-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) OYKGMOVRDZQXJB-UHFFFAOYSA-N 624953 US20230322745, Compound 24 Muscarinic acetylcholine receptor M2 Homo sapiens 0.014 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624953 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624953&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422843 485207319 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332474 O[C@@H](CNCc1cc2nnn(CCCN3CCC4(C[C@@H](CO4)OC(=O)C(O)(c4cccs4)c4cccs4)CC3)c2c2CCCc12)c1ccc(O)c2[nH]c(=O)ccc12 |r| InChI=1S/C42H46N6O7S2/c49-33-11-9-29(30-10-12-37(51)44-38(30)33)34(50)24-43-23-26-21-32-39(31-6-1-5-28(26)31)48(46-45-32)16-4-15-47-17-13-41(14-18-47)22-27(25-54-41)55-40(52)42(53,35-7-2-19-56-35)36-8-3-20-57-36/h2-3,7-12,19-21,27,34,43,49-50,53H,1,4-6,13-18,22-25H2,(H,44,51) OYKGMOVRDZQXJB-UHFFFAOYSA-N 624955 US20230322745, Compound 25 Muscarinic acetylcholine receptor M2 Homo sapiens 0.030 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624955 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624955&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422845 485207321 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332475 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(Cl)s1 |r,wU:37.45,43.49,wD:14.14,43.50,(3.77,3.25,;4.17,4.74,;3.08,5.83,;1.59,5.43,;.5,6.52,;-.98,6.12,;-1.61,4.72,;-3.14,4.88,;-3.46,6.38,;-4.8,7.15,;-4.8,8.69,;-6.13,9.46,;-7.46,8.69,;-8.8,9.46,;-10.13,8.69,;-10.13,7.15,;-11.46,9.46,;-12.8,8.69,;-14.13,9.46,;-14.13,11,;-15.46,11.77,;-12.8,11.77,;-12.8,13.31,;-11.46,14.08,;-11.46,15.62,;-10.13,13.31,;-10.13,11.77,;-11.46,11,;-3.46,9.46,;-3.14,10.97,;-1.61,11.13,;-.98,9.72,;-2.13,8.69,;-2.13,7.15,;5.66,5.14,;6.75,4.05,;8.23,4.45,;8.63,5.94,;7.54,7.03,;6.06,6.63,;10.12,6.34,;10.52,7.82,;9.43,8.91,;12.01,8.22,;13.49,8.62,;12.4,9.71,;11.44,10.91,;12.27,12.2,;13.76,11.8,;13.84,10.26,;13.09,7.13,;14.56,7.61,;15.46,6.36,;14.56,5.12,;15.04,3.65,;13.09,5.59,)| InChI=1S/C41H45ClN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) CZFARYRCUMIUSD-UHFFFAOYSA-N 624956 US20230322745, Compound 28 Muscarinic acetylcholine receptor M2 Homo sapiens 0.083 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624956&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422846 485207322 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332476 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(Cl)s1 |r,wU:37.45,43.50,wD:14.14,43.49,(3.77,3.25,;4.17,4.74,;3.08,5.83,;1.59,5.43,;.5,6.52,;-.98,6.12,;-1.61,4.72,;-3.14,4.88,;-3.46,6.38,;-4.8,7.15,;-4.8,8.69,;-6.13,9.46,;-7.46,8.69,;-8.8,9.46,;-10.13,8.69,;-10.13,7.15,;-11.46,9.46,;-12.8,8.69,;-14.13,9.46,;-14.13,11,;-15.46,11.77,;-12.8,11.77,;-12.8,13.31,;-11.46,14.08,;-11.46,15.62,;-10.13,13.31,;-10.13,11.77,;-11.46,11,;-3.46,9.46,;-3.14,10.97,;-1.61,11.13,;-.98,9.72,;-2.13,8.69,;-2.13,7.15,;5.66,5.14,;6.75,4.05,;8.23,4.45,;8.63,5.94,;7.54,7.03,;6.06,6.63,;10.12,6.34,;10.52,7.82,;9.43,8.91,;12.01,8.22,;13.49,8.62,;12.4,9.71,;11.44,10.91,;12.27,12.2,;13.76,11.8,;13.84,10.26,;13.09,7.13,;14.56,7.61,;15.46,6.36,;14.56,5.12,;15.04,3.65,;13.09,5.59,)| InChI=1S/C41H45ClN6O6S2/c1-47(25-8-10-26(11-9-25)54-40(52)41(53,34-7-3-20-55-34)35-15-16-36(42)56-35)18-4-19-48-39-30-6-2-5-27(30)24(21-31(39)45-46-48)22-43-23-33(50)28-12-14-32(49)38-29(28)13-17-37(51)44-38/h3,7,12-17,20-21,25-26,33,43,49-50,53H,2,4-6,8-11,18-19,22-23H2,1H3,(H,44,51) CZFARYRCUMIUSD-UHFFFAOYSA-N 624957 US20230322745, Compound 29 Muscarinic acetylcholine receptor M2 Homo sapiens 0.146 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624957 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624957&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422847 485207323 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332477 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)[C@H]1CC[C@H](CC(=O)C(O)(c2ccc(C)s2)c2ccc(C)s2)CC1 |r,wU:34.38,wD:14.14,37.42,(4.51,-4.78,;4.51,-3.24,;3.17,-2.47,;1.84,-3.24,;.5,-2.47,;-.83,-3.24,;-1.07,-4.76,;-2.59,-5,;-3.29,-3.63,;-4.78,-3.23,;-5.18,-1.74,;-6.66,-1.34,;-7.75,-2.43,;-9.24,-2.03,;-10.33,-3.12,;-9.93,-4.61,;-11.82,-2.72,;-12.91,-3.81,;-14.39,-3.41,;-14.79,-1.93,;-16.28,-1.53,;-13.7,-.84,;-14.1,.65,;-13.01,1.74,;-13.41,3.23,;-11.52,1.34,;-11.13,-.15,;-12.22,-1.24,;-4.09,-.65,;-4.17,.89,;-2.73,1.44,;-1.76,.24,;-2.6,-1.05,;-2.2,-2.54,;5.84,-2.47,;5.84,-.93,;7.17,-.16,;8.51,-.93,;9.84,-.16,;11.17,-.93,;11.17,-2.47,;12.51,-.16,;13.84,.61,;13.84,-.93,;15.25,-.3,;16.28,-1.44,;15.51,-2.78,;16.14,-4.19,;14,-2.46,;12.51,1.38,;11.26,2.29,;11.74,3.75,;13.28,3.75,;14.18,5,;13.75,2.29,;8.51,-2.47,;7.17,-3.24,)| InChI=1S/C44H52N6O5S2/c1-26-8-17-39(56-26)44(55,40-18-9-27(2)57-40)38(53)22-28-10-12-30(13-11-28)49(3)20-5-21-50-43-34-7-4-6-31(34)29(23-35(43)47-48-50)24-45-25-37(52)32-14-16-36(51)42-33(32)15-19-41(54)46-42/h8-9,14-19,23,28,30,37,45,51-52,55H,4-7,10-13,20-22,24-25H2,1-3H3,(H,46,54) JSDLJSSEKWSNAT-UHFFFAOYSA-N 624959 US20230322745, Compound 32 Muscarinic acetylcholine receptor M2 Homo sapiens 0.814 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624959&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422849 485207325 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332478 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C39H42N6O8S2/c1-44(24-7-9-25(10-8-24)53-38(49)39(50,31-5-2-17-54-31)32-6-3-18-55-32)15-4-16-45-35-28(42-43-45)19-23(36-37(35)52-22-51-36)20-40-21-30(47)26-11-13-29(46)34-27(26)12-14-33(48)41-34/h2-3,5-6,11-14,17-19,24-25,30,40,46-47,50H,4,7-10,15-16,20-22H2,1H3,(H,41,48) ZYYNDNILFMUVTL-UHFFFAOYSA-N 624960 US20230322745, Compound 33 Muscarinic acetylcholine receptor M2 Homo sapiens 0.153 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624960&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422850 485207326 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332479 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,1.47,;4.17,2.96,;3.08,4.04,;1.59,3.65,;.5,4.73,;-.98,4.34,;-1.61,2.93,;-3.14,3.09,;-3.46,4.6,;-4.8,5.37,;-4.8,6.91,;-6.13,7.68,;-7.46,6.91,;-8.8,7.68,;-10.13,6.91,;-10.13,5.37,;-11.46,7.68,;-12.8,6.91,;-14.13,7.68,;-14.13,9.22,;-15.46,9.99,;-12.8,9.99,;-12.8,11.53,;-11.46,12.3,;-11.46,13.84,;-10.13,11.53,;-10.13,9.99,;-11.46,9.22,;-3.46,7.68,;-3.14,9.18,;-1.61,9.34,;-.98,7.94,;-2.13,6.91,;-2.13,5.37,;5.66,3.35,;6.06,4.84,;7.54,5.24,;8.63,4.15,;8.23,2.66,;6.75,2.26,;10.12,4.55,;10.52,6.04,;9.43,7.13,;12.01,6.44,;13.49,6.83,;12.4,7.92,;11.44,9.12,;12.27,10.41,;13.76,10.01,;13.84,8.47,;13.09,5.35,;14.56,5.82,;15.46,4.58,;14.56,3.33,;15.04,1.87,;13.09,3.81,)| InChI=1S/C40H44N6O8S2/c1-23-6-14-33(56-23)40(51,32-5-3-18-55-32)39(50)54-26-9-7-25(8-10-26)45(2)16-4-17-46-36-29(43-44-46)19-24(37-38(36)53-22-52-37)20-41-21-31(48)27-11-13-30(47)35-28(27)12-15-34(49)42-35/h3,5-6,11-15,18-19,25-26,31,41,47-48,51H,4,7-10,16-17,20-22H2,1-2H3,(H,42,49) FYYWKHFZJYSOCA-UHFFFAOYSA-N 624961 US20230322745, Compound 34 Muscarinic acetylcholine receptor M2 Homo sapiens 0.248 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624961 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624961&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422851 485207327 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332480 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3OCOc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,1.47,;4.17,2.96,;3.08,4.04,;1.59,3.65,;.5,4.73,;-.98,4.34,;-1.61,2.93,;-3.14,3.09,;-3.46,4.6,;-4.8,5.37,;-4.8,6.91,;-6.13,7.68,;-7.46,6.91,;-8.8,7.68,;-10.13,6.91,;-10.13,5.37,;-11.46,7.68,;-12.8,6.91,;-14.13,7.68,;-14.13,9.22,;-15.46,9.99,;-12.8,9.99,;-12.8,11.53,;-11.46,12.3,;-11.46,13.84,;-10.13,11.53,;-10.13,9.99,;-11.46,9.22,;-3.46,7.68,;-3.14,9.18,;-1.61,9.34,;-.98,7.94,;-2.13,6.91,;-2.13,5.37,;5.66,3.35,;6.06,4.84,;7.54,5.24,;8.63,4.15,;8.23,2.66,;6.75,2.26,;10.12,4.55,;10.52,6.04,;9.43,7.13,;12.01,6.44,;13.49,6.83,;12.4,7.92,;11.44,9.12,;12.27,10.41,;13.76,10.01,;13.84,8.47,;13.09,5.35,;14.56,5.82,;15.46,4.58,;14.56,3.33,;15.04,1.87,;13.09,3.81,)| InChI=1S/C40H44N6O8S2/c1-23-6-14-33(56-23)40(51,32-5-3-18-55-32)39(50)54-26-9-7-25(8-10-26)45(2)16-4-17-46-36-29(43-44-46)19-24(37-38(36)53-22-52-37)20-41-21-31(48)27-11-13-30(47)35-28(27)12-15-34(49)42-35/h3,5-6,11-15,18-19,25-26,31,41,47-48,51H,4,7-10,16-17,20-22H2,1-2H3,(H,42,49) FYYWKHFZJYSOCA-UHFFFAOYSA-N 624962 US20230322745, Compound 35 Muscarinic acetylcholine receptor M2 Homo sapiens 0.588 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624962&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422852 485207328 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332481 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,.8,;4.17,2.29,;3.08,3.38,;1.59,2.98,;.5,4.07,;-.98,3.67,;-1.61,2.26,;-3.14,2.42,;-3.46,3.93,;-4.8,4.7,;-4.8,6.24,;-6.13,7.01,;-7.46,6.24,;-8.8,7.01,;-10.13,6.24,;-10.13,4.7,;-11.46,7.01,;-12.8,6.24,;-14.13,7.01,;-14.13,8.55,;-15.46,9.32,;-12.8,9.32,;-12.8,10.86,;-11.46,11.63,;-11.46,13.17,;-10.13,10.86,;-10.13,9.32,;-11.46,8.55,;-3.46,7.01,;-3.14,8.51,;-1.61,8.68,;-.98,7.27,;-2.13,6.24,;-2.13,4.7,;5.66,2.69,;6.06,4.17,;7.54,4.57,;8.63,3.48,;8.23,2,;6.75,1.6,;10.12,3.88,;10.52,5.37,;9.43,6.46,;12.01,5.77,;13.49,6.17,;12.4,7.26,;11.44,8.45,;12.27,9.74,;13.76,9.35,;13.84,7.81,;13.09,4.68,;14.56,5.15,;15.46,3.91,;14.56,2.66,;15.04,1.2,;13.09,3.14,)| InChI=1S/C41H46N6O7S2/c1-24-6-14-36(56-24)41(52,35-5-3-18-55-35)40(51)54-27-9-7-26(8-10-27)46(2)16-4-17-47-39-31-23-53-22-30(31)25(19-32(39)44-45-47)20-42-21-34(49)28-11-13-33(48)38-29(28)12-15-37(50)43-38/h3,5-6,11-15,18-19,26-27,34,42,48-49,52H,4,7-10,16-17,20-23H2,1-2H3,(H,43,50) ITYRYCDVBXJIPH-UHFFFAOYSA-N 624963 US20230322745, Compound 36 Muscarinic acetylcholine receptor M2 Homo sapiens 1.74 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624963 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624963&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422853 485207329 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332482 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,.8,;4.17,2.29,;3.08,3.38,;1.59,2.98,;.5,4.07,;-.98,3.67,;-1.61,2.26,;-3.14,2.42,;-3.46,3.93,;-4.8,4.7,;-4.8,6.24,;-6.13,7.01,;-7.46,6.24,;-8.8,7.01,;-10.13,6.24,;-10.13,4.7,;-11.46,7.01,;-12.8,6.24,;-14.13,7.01,;-14.13,8.55,;-15.46,9.32,;-12.8,9.32,;-12.8,10.86,;-11.46,11.63,;-11.46,13.17,;-10.13,10.86,;-10.13,9.32,;-11.46,8.55,;-3.46,7.01,;-3.14,8.51,;-1.61,8.68,;-.98,7.27,;-2.13,6.24,;-2.13,4.7,;5.66,2.69,;6.06,4.17,;7.54,4.57,;8.63,3.48,;8.23,2,;6.75,1.6,;10.12,3.88,;10.52,5.37,;9.43,6.46,;12.01,5.77,;13.49,6.17,;12.4,7.26,;11.44,8.45,;12.27,9.74,;13.76,9.35,;13.84,7.81,;13.09,4.68,;14.56,5.15,;15.46,3.91,;14.56,2.66,;15.04,1.2,;13.09,3.14,)| InChI=1S/C41H46N6O7S2/c1-24-6-14-36(56-24)41(52,35-5-3-18-55-35)40(51)54-27-9-7-26(8-10-27)46(2)16-4-17-47-39-31-23-53-22-30(31)25(19-32(39)44-45-47)20-42-21-34(49)28-11-13-33(48)38-29(28)12-15-37(50)43-38/h3,5-6,11-15,18-19,26-27,34,42,48-49,52H,4,7-10,16-17,20-23H2,1-2H3,(H,43,50) ITYRYCDVBXJIPH-UHFFFAOYSA-N 624964 US20230322745, Compound 37 Muscarinic acetylcholine receptor M2 Homo sapiens 2.01 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624964&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422854 485207330 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332483 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.49,wD:14.14,37.45,43.50,(3.77,1.68,;4.17,3.17,;3.08,4.26,;1.59,3.86,;.5,4.95,;-.98,4.55,;-1.61,3.15,;-3.14,3.31,;-3.46,4.81,;-4.8,5.58,;-4.8,7.12,;-6.13,7.89,;-7.46,7.12,;-8.8,7.89,;-10.13,7.12,;-10.13,5.58,;-11.46,7.89,;-12.8,7.12,;-14.13,7.89,;-14.13,9.43,;-15.46,10.2,;-12.8,10.2,;-12.8,11.74,;-11.46,12.51,;-11.46,14.05,;-10.13,11.74,;-10.13,10.2,;-11.46,9.43,;-3.46,7.89,;-3.14,9.4,;-1.61,9.56,;-.98,8.15,;-2.13,7.12,;-2.13,5.58,;5.66,3.57,;6.06,5.06,;7.54,5.46,;8.63,4.37,;8.23,2.88,;6.75,2.48,;10.12,4.77,;10.52,6.25,;9.43,7.34,;12.01,6.65,;13.49,7.05,;12.4,8.14,;11.44,9.34,;12.27,10.63,;13.76,10.23,;13.84,8.69,;13.09,5.56,;14.56,6.04,;15.46,4.79,;14.56,3.55,;15.04,2.08,;13.09,4.02,)| InChI=1S/C43H49N5O6S2/c1-26-9-17-38(56-26)43(53,37-8-4-21-55-37)42(52)54-29-12-10-28(11-13-29)47(2)19-5-20-48-25-45-34-22-27(30-6-3-7-33(30)41(34)48)23-44-24-36(50)31-14-16-35(49)40-32(31)15-18-39(51)46-40/h4,8-9,14-18,21-22,25,28-29,36,44,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,46,51) UBDKDGUJMUUUTQ-UHFFFAOYSA-N 624965 US20230322745, Compound 38 Muscarinic acetylcholine receptor M2 Homo sapiens 0.842 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624965&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422855 485207331 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332484 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)[C@@](O)(c1cccs1)c1ccc(C)s1 |r,wU:43.50,wD:14.14,37.45,43.49,(3.77,1.68,;4.17,3.17,;3.08,4.26,;1.59,3.86,;.5,4.95,;-.98,4.55,;-1.61,3.15,;-3.14,3.31,;-3.46,4.81,;-4.8,5.58,;-4.8,7.12,;-6.13,7.89,;-7.46,7.12,;-8.8,7.89,;-10.13,7.12,;-10.13,5.58,;-11.46,7.89,;-12.8,7.12,;-14.13,7.89,;-14.13,9.43,;-15.46,10.2,;-12.8,10.2,;-12.8,11.74,;-11.46,12.51,;-11.46,14.05,;-10.13,11.74,;-10.13,10.2,;-11.46,9.43,;-3.46,7.89,;-3.14,9.4,;-1.61,9.56,;-.98,8.15,;-2.13,7.12,;-2.13,5.58,;5.66,3.57,;6.06,5.06,;7.54,5.46,;8.63,4.37,;8.23,2.88,;6.75,2.48,;10.12,4.77,;10.52,6.25,;9.43,7.34,;12.01,6.65,;13.49,7.05,;12.4,8.14,;11.44,9.34,;12.27,10.63,;13.76,10.23,;13.84,8.69,;13.09,5.56,;14.56,6.04,;15.46,4.79,;14.56,3.55,;15.04,2.08,;13.09,4.02,)| InChI=1S/C43H49N5O6S2/c1-26-9-17-38(56-26)43(53,37-8-4-21-55-37)42(52)54-29-12-10-28(11-13-29)47(2)19-5-20-48-25-45-34-22-27(30-6-3-7-33(30)41(34)48)23-44-24-36(50)31-14-16-35(49)40-32(31)15-18-39(51)46-40/h4,8-9,14-18,21-22,25,28-29,36,44,49-50,53H,3,5-7,10-13,19-20,23-24H2,1-2H3,(H,46,51) UBDKDGUJMUUUTQ-UHFFFAOYSA-N 624966 US20230322745, Compound 39 Muscarinic acetylcholine receptor M2 Homo sapiens 1.25 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624966&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422856 485207332 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332485 CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3COCc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C40H44N6O7S2/c1-45(25-7-9-26(10-8-25)53-39(50)40(51,34-5-2-17-54-34)35-6-3-18-55-35)15-4-16-46-38-30-23-52-22-29(30)24(19-31(38)43-44-46)20-41-21-33(48)27-11-13-32(47)37-28(27)12-14-36(49)42-37/h2-3,5-6,11-14,17-19,25-26,33,41,47-48,51H,4,7-10,15-16,20-23H2,1H3,(H,42,49) NTARVXTWEZJQNE-UHFFFAOYSA-N 624967 US20230322745, Compound 40 Muscarinic acetylcholine receptor M2 Homo sapiens 0.228 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624967 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624967&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422857 485207333 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 1332486 CN(CCCn1cnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c3CCCc3c12)C1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |r,wD:14.14,37.45,(3.77,-6.18,;4.17,-4.7,;3.08,-3.61,;1.59,-4.01,;.5,-2.92,;-.98,-3.32,;-1.61,-4.72,;-3.14,-4.56,;-3.46,-3.06,;-4.8,-2.29,;-4.8,-.75,;-6.13,.02,;-7.46,-.75,;-8.8,.02,;-10.13,-.75,;-10.13,-2.29,;-11.46,.02,;-12.8,-.75,;-14.13,.02,;-14.13,1.56,;-15.46,2.33,;-12.8,2.33,;-12.8,3.87,;-11.46,4.64,;-11.46,6.18,;-10.13,3.87,;-10.13,2.33,;-11.46,1.56,;-3.46,.02,;-3.14,1.53,;-1.61,1.69,;-.98,.28,;-2.13,-.75,;-2.13,-2.29,;5.66,-4.3,;6.06,-2.81,;7.54,-2.41,;8.63,-3.5,;8.23,-4.99,;6.75,-5.39,;10.12,-3.1,;10.52,-1.62,;9.43,-.53,;12.01,-1.22,;13.49,-.82,;12.4,.27,;11.44,1.47,;12.27,2.76,;13.76,2.36,;13.84,.82,;13.09,-2.31,;14.56,-1.83,;15.46,-3.08,;14.56,-4.32,;13.09,-3.85,)| InChI=1S/C42H47N5O6S2/c1-46(27-10-12-28(13-11-27)53-41(51)42(52,36-8-3-20-54-36)37-9-4-21-55-37)18-5-19-47-25-44-33-22-26(29-6-2-7-32(29)40(33)47)23-43-24-35(49)30-14-16-34(48)39-31(30)15-17-38(50)45-39/h3-4,8-9,14-17,20-22,25,27-28,35,43,48-49,52H,2,5-7,10-13,18-19,23-24H2,1H3,(H,45,50) UFQHICFQEIEWLF-UHFFFAOYSA-N 624969 US20230322745, Compound 41 Muscarinic acetylcholine receptor M2 Homo sapiens 0.268 US Patent 10.7270/Q2T157SH aid1919843 US20230322745 ZHANG, P; LUO, Y; GAO, F; CHEN, S 10/12/2023 11/22/2023 Chia Tai Tianqing Pharmaceutical Group http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=624969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=624969&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 169422859 485207335 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9